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CHAPTER 1 GENERAL INTRODUCTION 
 
This dissertation explores the relevance of G protein-coupled receptors in disease causing protozoans 
and free living flatworms.  It explored the biological importance of a catecholamine responsive 
GPCR in Tetrahymena and the physiological importance of serotonergic receptors in the locomotory 
events of two species of flatworms; Girardia tigrina and Schmidtea mediterranea.  During the 
preliminary studies, a protozoan GPCR was obtained by genome mining, cloned and heterologously 
expressed in a yeast expression system, subjected to agonist treatment, and hence, de-orphanized.  
The serotonin GPCRs in both Schmidtea mediterranea and Girardia tigrina were cloned into 
Gateway vector with which double stranded RNA production was induced in an RNAse III deficient 
bacterial strain for RNAi studies.  Overall, the work has two main goals. 
 
First, a protozoan disease such as tetrahymenosis is an important ailment that affects aquatic life and 
consequently, Humans.  The biology of Tetrahymena catecholamine responsiveness and 
phagocytosis provides a clue to the regulation of Tetrahymena survival.  Second, the existence of 
homologues of most flatworm genes in very important Human parasites as well as Humans, explains 
the rationale behind the study of these cell surface receptors in the phyla Platyhelminthes.  A 
common denominator to these two phyla is their large dependence on monoamines.  The future goal 
is to eventually explore if these gene homologs have similar and exploitable functional roles in 






1.1 Dissertation organization 
Chapter 1 gives the general overview of G protein-coupled receptors (GPCRs) and the families 
therein, the essential features of GPCRs and their mechanism of activation; a brief description of the 
various families constituting the GPCRs superfamily, and techniques required in rescuing the 
supposedly ‘perishing’ orphan GPCRs.  It continues to describe the genesis of an alternative loss-of- 
function technique that was originally discovered accidentally in petunias and culminating in the 
streamlining of the mechanism of RNAi.  Chapter 2 enumerates the step-by-step processes involved 
in the deorphanization of a catecholamine-responsive protozoan GPCR involved in bacterial 
engulfment, dubbed, TetEPI-1.  
 
Chapter 3 describes the characterization of serotonergic GPCRs mediating motility in Giraria tigrina 
and Schmidtea mediterranea in a reverse pharmacological process employing an established 
alternative loss-of-function (small interfering RNA) technique.  It identifies the G protein-coupling 
profiles of the serotonergic receptors by monitoring forskolin-stimulated adenylate cyclase/cAMP 
levels as important messengers involved in GPCR signaling in response to ligand stimulation.  
Chapter 4 generally narrows down the main findings of this work and concludes by outlining the big 
picture of the principles of deorphanization of biogenic amine-sensitive GPCRs mediating planarian 
motility and protozoan phagocytosis using heterologous expression, alternative-loss-of function 
technique coupled with transductional coupling determination, and the monitoring of phenotypes.  
 
Appendix A and B constitute two manuscripts to which I have contributed; the first describes the 
optimization and the establishment of an alternative loss-of-function protocol for the 
deorphanization of putative GPCRs; the second describes the heterologous expression-based 
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deorphanization of a protozoan GPCR, EhGPCR-1, relevant to phagocytic pathways of pathogenic 
E. histolytica.  These two appendices provide a substantial scope of two established means of 
deorphanization of GPCRs.  Appendix C, D, E and F constitute RNAi protocols, optimized cAMP 
determination protocols, double T7 dsRNA inducible vector map and target sequences, respectively. 
 
1.2 G protein-coupled receptors defined 
GPCRs are also known as heptahelical receptors, serpentine receptors, G protein-linked receptors 
(GPLR) or 7-transmembrane (7TM) domain receptors.  GPCRs are cell surface receptors which 
serve in the transduction of extracellular stimuli into intracellular signals, i.e., they serve as 
intermediaries between extracellular stimuli and intracellular signals/mechanisms.  They mediate 
senses such as vision, smell, taste, and pain (Trabanino et al., 2004) and are indispensable among 
membrane proteins because they constitute the largest and most diverse groups of receptor proteins 
(Teller et al., 2001).  These transmembrane proteins are essential for all multicellular eukaryotes.  
 
In humans, >1000 of 22,000 genes code for GPCRs (Fredriksson and Schiöth, 2005),  most of which 
influence embryogenesis and development by the reception of signals from hormones, 
neurotransmitters and environmental cues to different magnitudes hence, different degrees of 
physiological differences observed in infant development (Latronico and Hochberg, 2010).  In mice, 
392 genes code for GPCRs (Demetrios et al., 2003) and the lack of the G protein-coupling protein, 
Gα13, results in embryonic lethality at mid-gestation (Wettschureck and Offermanns, 2005).  In 
colonies of the budding yeast, Saccharomyces cerevisiae, 3 of its 5,900 genes encode GPCRs 
(Overton et al., 2005).  The functional stimulation of these 7-transmembrane proteins in yeast is 
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coupled to their pheromone-response pathway, a well exploited system for ligand identification and 
characterization of receptor pharmacology and signal transduction (Dowell and Brown, 2009).  
 
Even though they constitute just 3–4% (Schoneberg et al., 2002) of the human genome, defects in 
GPCR genes contribute to an array of diseases such as allergies, asthma, anxiety, congestive heart 
failure, glaucoma, heartburn, hypertension, migraine, Parkinson's, psychosis, schizophrenia, ulcers, 
etc. (Wilson and Bergsma, 2000).  It is therefore, evident that GPCRs represent one of the most 
important families of drug targets.  With the establishment of their importance as targets of 30-50% 
of drugs, their search has been on the increase and even though a number of them are currently 
identified and paired with known ligands, most still exist with no known ligands.  
 
GPCRs to which there are no known ligands are described as orphan GPCRs (oGPCRs).  It has been 
demonstrated that oGPCRs: may have relevant ligand-independent functions; can modulate the 
function of GPCRs with known ligands; serve as transporters of neurotransmitter via physical 
association with these molecules, a phenomenon termed constitutive activity of orphan 7TM proteins 
(Levoye and Jockers, 2008) discussed later in this chapter.  Despite these revelations, the most 
pursued goal has been to deorphanize these oGPCRs considering the complex nature of investigation 








1.2.1  GPCR structure 
Structurally, GPCRs have seven transmembrane α-helices forming the TM core.  Transmembrane 
domains are linked by six loops of varying length (Palczewski et al., 2000); three exo-loops and 
three cyto-loops as shown in Fig. 1.1.  GPCRs also bear an extracellular amino-terminal segment and 
an intracellular carboxy-terminal segment, a topology predicted based on hydropathy profiles and 
the crystal structure of the class I GPCR, visual pigment rhodopsin (Palczewski et al., 2000).  
Palmitoylation of the carboxy-terminal segment at a cysteine residue results in the formation of a 
fourth cytoplasmic loop (Ali et al., 1997).  While there is no common ligand binding site, the 
hydrophobic core formed by the transmembrane provides localized binding sites for small molecular 
weight ligands, with peptides and protein ligands binding preferentially to N-terminus and the 
extracellular hydrophobic loops (Gether and Kobilka, 1998).  The structure allows glycosylation (at 
the N-terminus) and phosphorylation at the C-terminal segment relevant for desensitization 
(Lefkowitz, 1998) and also provides appropriate site of contact for G proteins at the second and third 
cytoplasmic loops including the C terminus (Gether and Kobilka, 1998).   
 
A TM of 24 in the case of ion channels, results in the selective exclusion of ions greater than 5 Ǻ (Ji 
et al., 1998) due to the compact nature of the TMs.  The TMs are linked extensively with hydrogen 
bonds (Pebay-Peyroula et al., 1997; Sealfon et al., 1997).  There is the view that TM 1, 4 and 7 are 
more exposed to the lipid bilayer, hence, more hydrophobic compared to the others (Ji et al., 1998).  
The first two exo-loops are known to contain two conserved Cys residues linked by disulfide bonds 
in bovine rhodopsin (Ji et al., 1998), for example.  Disulfide bonds are historically known for their 
protective role: promote folding and stability of some proteins especially, proteins secreted to the 
6 
 
extracellular medium (Darby and Creighton, 1995).  The existence of the strong disulfide bond, a 
covalent bond within the structure, partly explains the fixed nature of the bulk of these receptors.   
                                            
 
 
Figure 1.1 Conserved features of typical GPCRs 
A two dimensional representation of a GPCR, showing the 7TMs interconnected by the 3 
intracellular loops (ICL) and the 3 extracellular loops (ECL).  Alignment of amino acid sequences 
(residues 138 to 158) of intracellular loop II (2i) of the following GPCRs: murine gonadotropin-
releasing hormone receptor; human muscarinic acetylcholine receptor (m1-R)(Peralta et al., 1987 ); 
human β2-adrenergic receptor (Kobilka  et al., 1987); human serotonin 1d receptor (Hamblin and Metcalf, 
1991); odorant F3 receptor (Arora et al., 1995); mouse thyrotropin-releasing hormone (TRH) receptor (Straub 
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et al., 1990); human rhodopsin receptor (Nathans and Hogness, 1984); rat cannabinoid receptor (Matsuda et 
al., 1990); bovine angiotensin II (Sasaki et al., 1991); rat luteinizing hormone (McFarland et al., 1989) and rat 
thyroid stimulating hormone (TSH) (Akamizu et al., 1990); shows conserved hydrophobic amino acid 
residues; e.g. DRY [Aspartate (D), Arginine(R), Tyrosine(Y)] in “vertical box”; Modified from (Arora et 
al., 1995; Gether and Kobilka, 1998). 
 
1.3 G proteins 
G proteins are cytosolic or membrane-associated proteins which exist in their inactive state as a 
heterotrimeric complex with subunits designated as α, β and γ.  They are named G proteins because 
they bind the guanine nucleotides, GTP and GDP.  They are grouped into four families: Gs (s, olf), Gi (i, o, 
z, t), Gq (q, 11), and G12 (12, 13) with respect to sequence homology and functional similarities of their α 
subunits (Hepler, 2003; Simon et al., 1991; Thomsen et al., 2005).  When inactive, GDP remains 
bound to the Gα subunit as Gα-GDP.  When GDP is replaced by GTP, the G protein is activated.  
 
1.3.1  The Gα subunit 
The Gα subunits of each of these four families have GTPase, receptor, effector, Gβγ binding domains 
(Neer, 1995) and a helical GTP binding domain.  The helical domain is divergent in the Gα subunit 
of the four families (Oldham and Hamm, 2006).  Unlike the yeast system, the mammalian system 
has multiple G proteins and regulators of G protein signaling (RGS) (Oldham and Hamm, 2006).   
 
1.3.2  Designing the surrogate yeast system 
With a maximum of 3 relevant endogenous GPCRs in yeast, exogenous GPCR expression is 
exploitable by the elimination of the three endogenous GPCRs.  Consequently, GPCR-deleted 
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recombinant yeast serves as surrogates allowing for heterologous GPCR expression. In order to 
facilitate the coupling of mammalian GPCRs to the yeast system, the yeast G proteins need to be 
made to mimic those of the mammalian system.  Replacement of the yeast Gpa1 subunit with the 
mammalian homologue, Gα, was reported to have limited success in interaction with GPCRs due to 
low affinity of the mammalian Gα for the yeast Gβγ; and producing significant signaling background 
(Ladds et al., 2005).  In order to enhance the yeast “Gα-Gβγ” and non-yeast GPCR interaction, a series 
of chimeric Gα subunits were developed to incorporate receptor binding properties of mammalian Gα 
subunits into a Gpa1 subunit (Dowell and Brown, 2002) by the replacement of the distal C-terminus of 
the yeast Gpa1 with equivalent residues from various mammalian Gα subunits to yield products called 
Gα-transplants (Brown et al., 2000).  Unlike the Gpa1 alone, the resulting “yeast- mammalian” Gα 
chimera, Gpa1-Gα, efficiently couples to a variety of non-yeast GPCRs (Ladds et al., 2005).  The 
human B2-adrenergic receptor represents the first heterologously-expressed GPCR that coupled to 
the pheromone signaling pathway in yeast (King et al., 1990). 
 
1.3.3  Pitfalls 
Despite the alterations in the yeast Gα, only about 50% of GPCRs expressed heterologously are able 
to couple to the pheromone signaling pathway in S. cerevisiae (Dowell S.J. and Brown, 2002; Ladds 
et al., 2005).  Apart from the differences in lipid composition of yeast membranes compared to those 
of mammalian systems, a deficient interaction of the receptor with the Gα subunit following its 
expression and successful transport to cell surface, could still make the receptor inactive (Ladds et 
al., 2005; Lagane et al., 2000).  Ligand sizes also determine the ability of expressed GPCRs to get 
activated (Ladds et al., 2005).  Ligands with molecular weights (Mr)<1,000 daltons, are generally 
found to display GPCR activation potencies to similar magnitudes in yeast and mammals (Baranski 
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et al., 1999; Sachpatzidis et al., 2003), whereas larger ligands (MW>5,000 daltons) are less likely to 
activate GPCRs heterologously-expressed in the yeast system.  
 
1.3.4  The Gβγ subunit 
Various combinations of Gβ and Gγ subunit (Table 1.1) results in a number of Gβγ dimers of which 
not all are able to be activated (Dupré et al., 2009).  The Gβγ dimer functions in the inactivation of the 
Gα subunits, hence, the desensitization of the receptor (Kosaza, 2004; Shenoy and Lefkowitz, 2003).  
They also modulate Kir3 (G protein-gated inwardly rectifying potassium) channels, muscarinic 
potassium channels in the heart (Logothetis et al., 1987), voltage-gated calcium channels, 
phospholipase A2, GPCR kinases (Pitcher, 1998), and MAP kinases (McCudden et al., 2005). 
Table 1.1  G protein subunits in mammals 
 
  
1.4 Ligands and regions of interaction 
GPCRs recognize a range of ligands including hormones neurotransmitters, odorants, amino acids, 
chemokines, lipids, and light (GPCRs do not bind light) (Kroeze et al., 2003).  Apart from signal 
transduction via G proteins, some GPCRs are also capable of transducing signals via other signaling 
molecules such as Jak2 kinase, protein kinase c or phospholipase Cγ (Ji et al., 1998), an indication of 
the diversity in the GPCR superfamily.  While ligands such as biogenic amines, nucleosides, 
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eicosanoids, and lipid moieties binds exclusively to the TM core, peptides of ≤40 amino acids binds 
both the TM core and the exoloops; and while polypeptides of >40 but ≤90 amino acids bind to the 
core exo-loops and N-terminal segment, glycoproteins ≥30 kDa binds exclusively to the N-terminal 
segment. 
 




55 of the thrombin receptor at L
38DPR↓S42, yielding the peptide, Met1-
Arg
41.  The resulting shorter N-terminal segment interacts with exoloops to generate a signal, whereas the 
released peptide binds to platelets and stimulate platelet aggregation (Ji et al., 1998).  
  
1.4.1  Mechanism of activation 
Activation of GPCRs ensues following the binding of a ligand to the appropriate domain of the 
receptor.  The basic steps involved in the activation include ligand binding (signal generation), 
transmembrane signal transduction to cytoplasmic signaling molecules (Ji et al., 1998) via TM 
hydrogen bond reorganization.  Agonist binding induces a conformational change that may involve 
disruption of the strong ionic
 
interaction between the third and sixth transmembrane helices 
(Ballesteros et al., 2001; Shapiro et al., 2002)
 
resulting in the activation of the heterotrimeric G 
protein (by the activated GPCR) and affecting downstream signaling pathways (Neves et al., 2002) 
via the binding and activation of ubiquitous guanine nucleotide-binding regulatory proteins within 
the cytosol (Davies et al., 2007).  
 
Agonists bind basically to the long N-terminal tail of the secretin family of receptors to induce 
receptor activation but extracellular loop (EC) interaction is sometimes required to activate the 
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receptor (Dautzenberg et al., 1999; Stroop et al., 1996).  The EC loops provide the crucial contacts in 
the activation process (Kubo et al., 1998; Malherbe et al., 2003).  Another factor that influences 
GPCR activation is receptor dimerization, a phenomenon that occurs differently in the different 
classes of GPCRs suggesting that  it is however, not essential for activation of G protein(Cvejic and 
Devi, 1997; Hebert et al., 1996; Romano et al., 1996). 
 
1.4.2  Signal transduction through G proteins 
G proteins transmit signals across the plasma membrane as a result of conformational changes 
induced by ligand binding to the GPCR.  They in turn activate enzymes that regulate protein 
complexes resulting in the transduction of stimuli into signals affecting neurotransmission, growth, 
differentiation, or cell death.  The GDP bound or basal state (a complex of Gα, Gβ, and Gγ subunits) 
represents the inactive state of the heterodimer, linked to the cytosolic domain of the GPCR.  Upon 
activation, GTP replaces GDP on the Gα subunit, causing it to dissociate from the Gβγ dimer (figure 
1.2).  The Gα subunit interacts with effector molecules; enzymes such as adenylyl cyclase (AC) and 
phospholipase C (PLC-β), which in turn produce the second messengers: cAMP and intracellular 
calcium respectively (Gilman, 1987; Jones et al., 2004). 
 
Receptor downregulation occurs following repeated stimulation of the receptor resulting in signal 
attenuation or desensitization, via internalization (endocytosis) of the GPCR, a process facilitated by 
the binding of beta-arrestin (Laporte et al., 2002) to the cytosolic region of the receptor.  
Multifunctional proteins, designated as regulators of G protein signaling (RGS), regulate G protein 
signaling by binding to previously activated Gα to accelerate the  hydrolysis of  GTP to GDP, hence, 
inactivating the subunit resulting in the termination of signaling (Hollinger and Hepler, 2002).  
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Approximately 30 of these regulators are currently known with selectivity for Gα subfamilies 
(Wettschureck and Offermanns, 2005).  G protein-coupled receptor kinases (GRKs) that mediate 
receptor desensitization by phosphorylation of the cytosolic region of the receptor to prevent G 
protein coupling, however, are not found in yeast (Noble et al., 2003; Penn et al., 2000).  
 
 
Figure 1.2 Signal transduction through G proteins via GPCRs 
A non-stimulated GPCR as well as its coupling proteins (the heterotrimeric G proteins, Gα, β, γ) 
remain in the inactive state until stimulated by the binding of a ligand to the GPCR.  The α subunit 
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remains bound to a GDP at the inactive state.  Upon binding of a ligand to the GPCR, it becomes a 
guanine nucleotide exchange factor and induces the replacement of GDP with GTP on the Gα- 
subunit at the cytosolic side of the membrane as a result of the conformational change in the receptor 
following ligand binding.  The result of this nucleotide exchange is the dissociation of the Gα- 
subunit from the Gβγ-dimer subunit.  The dissociated Gα then activate other membrane proteins such 
as adenylyl cyclase, PLC-β, or PKC.  After the signal transduction, the inherent GTPase activity of 
the Gα subunit hydrolyzes the bound GTP to GDP + Pi resulting in inactivation of the of the Gα 
subunit.  It then re-associates with the Gβγ to the form the original inactive heterotrimeric complex 
Gαβγ, completing a cycle of activation and inactivation (Tuteja, 2009).  Figure modified from (Tuteja, 
2009). 
 
1.4.3  The stimulatory Gα/inhibitory Gα subunits (Gs/ Gi) 
The stimulatory G protein-coupled receptors (Gs-coupled receptors) are known to play an important 
role in proliferation and pluripotency (Layden et al., 2010), differentiation, and development of cells 
(Rosenberg et al., 2002).  Upon binding of an agonist, GPCRs coupled to the Gs subunit of a G 
protein, activate membrane-associated adenylyl cyclase (AC) (Gilman, 1987) following the 
exchange of GDP for GTP on the Gαs subunit.  AC yields cyclic AMP (cAMP) that binds the 
regulatory subunit and activates cAMP-dependent protein kinase A (PKA), GTP exchange proteins, 
or ion channels.  In addition to two regulatory subunits, PKA has two catalytic subunits which 
diffuse into the cell nucleus and phosphorylate the transcription factor CREB (cAMP Response 
Element Binding) at serine residue 133 (Gonzalez and Montminy, 1989).  The phosphorylated 
CREB then binds to CREB-binding protein (CBP) resulting in transactivation and expression of 
appropriate genes (Gonzalez and Montminy, 1989; Rosenberg et al., 2002).  Gs-coupled receptors 




The activation of GPCRs coupled to inhibitory Gα proteins (Gi-coupled receptor) on the other hand 
results in the inhibition of adenylyl cyclase hence, decrease in cAMP production.  They are known to 
play important roles in the wound healing response of cells (Babbin et al., 2007). 
 
1.4.4  The Gq subunit 
The regulatory subunit of G proteins has four classes, namely; Gαs, Gαi, Gαq, and Gα12.  The Gαq class 
(Gαq, Gα11, Gα14, Gα15/16) (Simon et al., 1991; Umemori et al., 1997) regulates PLC-β.  GPCRs-
activating Gq proteins, GqPCRs, are widely distributed in the CNS and regulate various neuronal 
processes, neuronal excitability, and synaptic plasticity (Augustine et al., 2003; Berridge, 1998; 
Billups et al., 2006).  Activated PLC-β hydrolyses PIP2 (phosphatidylinositol 4, 5-bisphosphate) to 
IP3 (inositol 1, 4, 5-trisphosphate) and DAG (diacylglycerol).  IP3 binds and activate IP3 receptors on 
endoplasmic reticulum resulting in the opening and release of Ca
2+
 from intracellular stores while 
DAG activates protein kinase C (PKC) (Berridge, 1993; Billups et al., 2006). 
 
GqPCR signaling is believed to be indirectly effected by membrane depolarization (Billups et al., 
2006) as a result of Ca
2+
 influx across the plasma membrane through ion channels.  The rationale is 
that the increase influx of Ca
2+
 results in increased magnitude of Ca
2+
 storage in the endoplasmic 
stores.  The filled endoplasmic Ca
2+
 stores increase the sensitivity of its extracellular IP3 receptors to 
IP3 readily available in the cytosol (Nakamura et al., 1999).  This in turn stimulates the IP3 signaling 
cascade, via positive regulation of PLC-β activity while neuronal cells with dynamic membrane 
potential however, directly influence GqPCRs signaling in their plasma membrane (Eberhard and 
Holz, 1988; Hashimotodani et al., 2005).  GPCR Signals transduction via Gq-mediated signaling 
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(e.g. STR-33) stimulates 5-HT biosynthesis and egg laying and also influences locomotion (Shyn et 
al., 2003; Tanis et al., 2008)  in C. elegans (Lee et al., 2011).  
 
1.4.5  The Gt subunit 
The chromosphere, 11-cis retinal, covalently linked to opsin GPCR (rhodopsin), upon the reception 
of light (ligand), gets converted to all-trans-retinal which changes the conformation of the opsin 
GPCR (Ridge et al., 2003).  The Gα.tranducin (Gα.gustducin, taste receptor associated) subunit 
released following the exchange of GDP for GTP, activates the membrane protein cyclic GMP 
(cGMP) phosphodiesterase which converts cGMP (retina only) to 5'-GMP causing the closure of 
cGMP-gated cation channels and resulting in cell hyperpolarization, hence the amplification of  the 







Figure 1.3 Downstream effector proteins on the path of G proteins 
Gα subunits released from G proteins following ligand [serotonin (5HT), Epinephrine (Epi)] binding 
to GPCR are variable and tend to have one of at least three fates: if a stimulatory(s) Gα, they pursue 
and activate adenylyl cyclase: if an inhibitory (i) Gα, they inhibit adenylyl cyclase resulting in 
decreased levels of the second messenger, cAMP.  The activation and translocation of the catalytic 
subunit of PKA (protein kinase A) into the nucleus to regulate transcription via CREB and CBP, is 
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determined by the levels of cAMP with the consequent phenotypic effect of these second messenger 
release being secretion, contraction, or motility.  If the released Gα is q-coupled, it pursues and 
activates phospholipase C-β, a potent enzyme that cleaves PIP2 into the second messengers; DAG 




 stores to affect hormone release contraction, 
ciliary beating, and other physiological processes.      
      
1.5 Computational methods for GPCR identification  
The challenge with GPCR identifications stems from the inability to effectively crystallize 
membrane proteins without dissolution in normal solvents (Li et al., 2010; Xiao X. et al., 2009).  To 
date, the only GPCRs structures resolved and available in their 3D conformation are the squid 
rhodopsin, β1, β2 adrenergic receptors, and the A2A adenosine receptor (Li et al., 2010).  However, 
the availability of amino acid sequence data from genomic sequences of various organisms are on 
the increase, giving rise to the need for most computational methods for fast and accurate prediction 
of the structure and function of GPCRs from sequence information.  
 
Some of these methods include the proteochemometric approach (Lapinsh et al., 2005), those based 
on similarity searches of using primary database search tools (e.g. BLAST, FASTA) coupled with 
searches of pattern databases (PRINTS)(Lapinsh et al., 2002) and those based on statistical and 
machine learning method, including support vector machines (SVM) (Bhasin and Raghava, 2004; 
Gupta et al., 2008; Karchin et al., 2002; Zamanian et al., 2011), hidden Markov models (HMMs) (Eo 
et al., 2007; Papasaikas et al., 2004; Papasaikas P.K. et al., 2003; Qian et al., 2003), nearest neighbor 
(NN) (Gao and Wang, 2006; Khan et al., 2008; Li et al., 2010) and covariant discriminant (CD) 
(Chou and Cai, 2002; Lapinsh et al., 2005).   
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1.5.1  A typical GPCR sequence structure prediction from genomic data  
The Support Vector Machine (SVM) has been used extensively to solve protein secondary structure 
(Guo et al., 2004; Kumar et al., 2005; Zamanian et al., 2011), subcellular localization (Chou and Cai, 
2002; Hua and Sun, 2001), and membrane protein types (Cai et al., 2003).  The product of these 
computational tools is the identification of amino acid sequences of more than a 1000 putative 
GPCRs.  The identification of these 7TM proteins from a given genome is largely dependent on 
various transmembrane domain protein prediction algorithms with the most used being the hidden 
Markov model topology prediction server, HMMTOP.  It predicts the localization of helical 
transmembrane segments as well as the topology of transmembrane proteins.  
 
The segment localizations and the topology are not determined by specific amino acid compositions 
of these helices but by the difference in distributions of the amino acid in various structural windows 
of these protein sequences (Tusnády and Simon, 1998).  Figure 1.4 shows a typical GPCR, a human 
5HT4 receptor variant b, with the various TMs colored.  The hydrophobic center (HC) for each 
helix, as calculated by prediction algorithms as the maximum of the peak of hydrophobicity from 
profile window sizes, determines its localization within the center of the membrane (Donnelly et al., 
















Figure 1.4 Homo sapiens 5-hydroxytryptamine (serotonin) receptor 4, variant b 
Showing the amino acid sequences of its TMs highlighted by the different colors as predicted by 
HMMTOP; and the conserved “DRY” amino acid residues (motif) of the second intracellular loop 
(2i: refer figure 1.1) seq :> gi|297206828|ref|NM_000870.5| Source: The Gene DB, 
ncbi.nlm.nih.gov, 01/15/2012. 
 
1.5.2  The GPCRDB  
The GPCRDB is a molecular information system that stores, validates, and disseminates sequence 
information on experimental data, ligand-binding constants, oligomers, and mutations and multiple 
sequence alignments of GPCRs (Vroling et al., 2011).  This data is automatically updated monthly at 
http://www.gpcr.org/7tm/.  Approximately 50 GPCRs are currently estimated to be targeted by half 
of all currently marketed drugs whereas at least 300 potentially exploitable ones still remain on 
bench (Chun et al., 2012; Lagerstrom and Schioth, 2008).   
 
GPCRs can be classified based on ligand specificity or on subfamilies.  Database search tools such 
as BLAST and FASTA (Altschul et al., 1990.) are employed in the classification of GPCRs into 
subfamilies but are thought to be effective only when the query protein sequence is largely similar to 
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the database sequences.  Others include the Hidden Markov models (Sreekumar et al., 2004) and the 
G protein and receptor interaction feature finding instrument (GRIFFIN) which employs both HMM 
and SVM (support Vector Machine) in the prediction of coupling selectivity such that both a ligand 
and a G protein prediction capability are incorporated, indicating a relationship between the identity 
of the extracellular ligand and the type of G protein it stimulates (Yabuki, 2005).  
 
1.6 GPCR classification 
Among the earliest GPCR classification systems is one introduced by Kolakowski in 1994 
(Kolakowski, 1994) in which GPCRs were divided into seven groups, designated A-F and O, based 
on standard (original) similarity searches.  A further development of the system for the GPCRDB 
database places GPCR into 6 classes namely: Class A Rhodopsin-like (> 80% of all GPCRs in 
humans); Class B Secretin-like; Class C Metabotropic glutamate receptors; Class D Pheromone 
receptors; Class E cAMP receptors; and the Class F Frizzled/smoothened family (Table 1.2) (Davies 
et al., 2007).   
 
While Classes A, B, C, and F are found in mammalian species, Class D proteins are characterized in 
fungi only and Class E proteins restricted to Dictyostelium (Davies et al., 2008).  The six classes are 
further divided into sub-divisions and sub-sub-divisions based on function and ligand specificity.  
The classes A GPCRs have seven identified subfamilies based on ligands, namely: muscarinic 
acetylcholine; histamine, serotonin, dopamine, octopamine, adrenoreceptors and trace amines (Horn 





1.6.1  The GRAFS classification 
The GRAFS system of classification is an alternative means of GPCR classification that recognizes 
the adhesion and secretin families as being separate; it distinguishes functional genes from 
pseudogenes (Davies et al., 2007).  It characterizes the GPCR superfamily into the Glutamates, 
Rhodopsins, Adhesions, Frizzled/ Taste 2 and Secretin families (GRAFS) (Schiöth et al., 2007).  A 
combination of protein families and protein domains were employed in the human genome project 
which revealed 616 GPCR sequences forming the A, B, and C classes of GPCRs while 569 GPCR 
were predicted by a motif based approach coupled with Interpro, to belong to the rhodopsin-like 

















Table 1.2  GPCR classes and families 
 
 
1.6.2  Class A receptors  
Rhodopsin belongs to the largest subfamily of the membrane receptors, constituting 90% of all 
GPCRs.  The crystal structure of rhodopsin forms the basis for the detailed three-dimensional 
structural model for a GPCR (Teller et al., 2001).  The low resolution (7.5 Å resolutions in the plane 
of the membrane and 16.5 Å resolutions, perpendicular to the membrane) three-dimensional study of 
rhodopsin indicated the location of the seven rods of density corresponding to transmembrane 
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helices.  This class constitutes a minimum of 286 human non-olfactory class A [I] receptors most of 
which bind biogenic amines, peptides, or lipid-like substances (Davies et al., 2007).  
 
1.6.3  Class B receptors  
The class B receptors constitute molecules believed to mediate intercellular interactions at the 
plasma membrane.  It includes a group of Drosophila proteins responsible for the regulation of stress 
responses and longevity (Nordström et al., 2009).  It binds large peptides such as secretin, calcitonin, 
glucagon, parathyroid hormone, and vasoactive intestinal peptide (VIP) (Cardoso et al., 2005).  The 
secretin GPCR is believed to descend from the adhesion family of GPCRs (Nordström et al., 2009) 
hence, are both designated as class B in the GPCRDB.  Secretin GPCRs have been characterized in 
mammals, Caenorhabditis elegans and Drosophila melanogaster, but not in plants, fungi or 
prokaryotes. 
 
Secretin was the first cloned GPCR of the class II family (Ishihara et al., 1991; Martin et al., 2005).  
The family has three distinct subfamilies of GPCRs (Harmar, 2001) namely B1, B2 and B3, each of 
which displayed coupling capabilities to the three G protein families; their activation results in the 
elevation of cAMP, suggesting Gs coupling (Martin et al., 2005); it has also demonstrated coupling 
to Gq and Gi proteins.  While the B1 Subclass interact with polypeptide hormones (27 to 141 amino 
acids); secretin, vasoactive intestinal peptide (VIP), glucagon, glucagon-like peptides (GLP-1, GLP-
2); glucose-dependent insulinotropic polypeptide (GIP) and growth hormone-releasing hormone 
(GHRH), the B2 and B3 subclasses interact with epidermal growth factor (EGF), i.e., EGF-7TM 





Class B (II) GPCRs are identified with relatively long N-terminus of approximately 120–140 amino 
acids with a set of six cysteine (Cys) residues linked by three disulphide bonds, a conserved feature 
in all GPCRs (Bazarsuren et al., 2002; Grauschopf et al., 2000).  While class I GPCRs rely on 
internal hydrophobic sequences for targeting to the plasma membrane, most class II GPCRs have an 
amino-terminal signal peptide for insertion into plasma membrane but lacks the class I GPCR motif, 
E/DRY.  While class I GPCRs have their IC3 being essential for heterotrimeric G protein 
interaction, the amino-terminal extracellular domain in class II GPCR is essential for ligand binding.  
A notable characteristic of class II GPCRs is that most are highly constitutive in their wild-type state 
while most class I’s are not, e.g. point mutation occurring in human PTH receptor resulting in severe 
hypocalcaemia and hyper-calciuria (Martin et al., 2005; Schipani et al., 1999).  
 
1.6.3.1  Subfamily B1 
The Subfamily B1 constitutes classical hormone receptors, encoded by 15 genes in humans.  
Glucagon, GLP-1 and GLP-2 which are members of the subfamily-B1 are synthesized post-
translationally from the single polypeptide precursor, proglucagon.  Members of the B1 subfamily 
regulate intracellular concentrations of cyclic AMP by means of adenylyl cyclase coupling via Gs 
signaling (Harmar, 2001). 
 
1.6.3.2   Adhesive GPCR Family B2 
The adhesive GPCRs, majority of which are still orphans, are designated in the GPCRDB as family 
B (Bjarnadóttir, 2007) or specifically B2 (Harmar, 2001).  They are also called epidermal growth 
factor-seven span transmembrane (EGF-TM7) receptors (Kwakkenbos et al., 2004), or the long N-
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terminal seven transmembrane receptors related to family B (LNB-TM7) (Stacey et al., 2000).  The 
debate still remains as to whether these adhesive GPCR are functionally coupled to G proteins.  
They are however, thought to play a role in cell-cell adhesion just like integrins and cadherins 
(Bjarnadóttir, 2007). 
 
In addition to an adhesive functional domain or more, they possess relatively long N-termini of more 
than thousand amino acids.  These functional domains are generally unique for the Adhesion 
members and not found within other GPCR families (Foord, 2002).  They are coded by numerous 
exons, making their genomic structure complex and difficult to study (Bjarnadóttir, 2007).  Some 
unique domains characterized in the N-termini of human Adhesion GPCRs using RPS-blast 
includes: GPS (GPCR proteolytic site), HBD (hormone binding domain), CA (cadherin repeats) 
EGF_Lam (laminin type Epidermal growth factor domain), GBL (galactose binding lectin domain), 
Ig (immunoglobulin domain), EGF_CA (epidermal growth factor, calcium binding domain), OLF 
(olfactomedin domain), LamG (laminin G domain), and LRR (leucine rich repeat) (Bjarnadóttir, 
2007). 
 
1.6.3.3  Subfamily B3 
The mutant cell line from Drosophila, methuselah (mth), a gene known to exert an average life span 
in Drosophila, represents the subfamily B3 of family-B GPCRs.  It demonstrates an increase in 
average lifespan of approximately 35 percent and shows enhanced resistance to stress conditions 
such as high temperature and starvation.  There is a minimum of eight paralogs of methuselah 
encoded within the Drosophila genome sequence but no such homologs of methuselah are 




1.6.4  Class C GPCRs 
The class III (C) GPCRs constitutes eight metabotropic glutamate receptors which are further 
classified into three main families (Table 1.3) (Pin and Acher, 2002).  They possess a large 
extracellular domain holding the binding sites distal to the 7TM and are capable of forming 
constitutive dimers with specific activation modes (Rondard et al., 2011).  With the high level of 
expression of these families in the CNS (Chun et al., 2012; Conn and Pin, 1997), they form essential 
targets for treatment of disorders of the nervous system such as Alzheimer's disease (Marino et al., 
2003) anxiety, schizophrenia (Conn et al., 2009), and Parkinson's disease (Johnson et al., 2009).   
 
Group I activate phospholipase C (PLC) and generate intracellular calcium signals via Gαq signaling.  
Both group II (mGlu2 and mGlu3) and group-III (mGlu4, mGlu6, mGlu7 and mGlu8), apart from 
adenylyl cyclase inhibition via Gαi/o signaling, regulate the activity of some ion channels (Goudet et 
al., 2004).  They have a bilobate extracellular domain, the so-called Venus Flytrap (VFT) module, a 
domain where endogenous ligands bind and are thought to be activated via an indirect metabotropic 
process (Pin et al., 2003).  The taste receptor classification has three members namely TR-1, TR-2, 









Table 1.3  Metabotropic GPCR groups and members 
 
 
1.6.5  Class D 
The class D family of GPCRs is composed of pheromone receptors, used for chemical 
communication (Nakagawa et al., 2005).  Some examples of this include fungal pheromone A 
factor-like (STE2 and STE3), fungal pheromone B-like (BAR, BBR) and fungal pheromone M- and 
P-factors. 
 
1.6.6  Class E 
Cyclic AMP receptors from slime molds are a unique family GPCR which regulate developmental 
processes in Dictyostelium.  They are known for the regulation of unicellular aggregation into 
multicellular organism (Klein et al., 1988). 
 
1.6.7  Frizzled/Smoothened receptors  
The Frizzled receptors are involved in Wnt signaling as well as mediates hedgehog signaling, a key 
regulator of animal development (Foord et al., 2002).  Wnts are signaling proteins that are secreted 
to regulate various processes of cell development.  Wnt signaling, when mediated by Wnt-10b, act as 
a molecular switch which regulates adipogenesis; and also act as morphogens forming a spectrum of 
concentrations that patterns the development of tissues (Coudreuse et al., 2006).  The binding of a 
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Wnt ligand to the frizzled (Fz)-Low density lipoprotein receptor Related Protein (LRP) results in the 
activation of the protein, designated as “disheveled” found in the cytoplasm (Dsh in Drosophila and 
Dvl in vertebrates) (Park et al., 2005), in a mechanism suspected to be a possible interaction with 
phospholipids Cong et al., 2003).  
 
1.7 GPCR deorphanization: scenarios and strategies 
1.7.1  Reverse pharmacology 
This describes a phenomenon in which sequence identification of a receptor is followed by the 
discovery of the corresponding ligand prior to pharmacological and physiological investigations, e.g. 
gene knockout or over-expression of the receptor and its ligand (Libert et al., 1991), a procedure 
opposite to classical physiology and pharmacology.  It constitutes three processes: library-based 
method, tissue extract based approach and information, or known ligand based approach.  In the 
library-based method, extensive substance libraries are designed to encompass predicted ligands for 
such receptors in addition to all known 7TM receptor ligands.  These are in turn matched with 
“orphan” receptor libraries, to identify positive hits (Brown et al., 2003).  
 
1.7.2  Orphan receptor strategy 
The endogenous ligands of approximately 140 GPCRs are still unknown, resulting in a large group 
of orphans, which are potentially important sources of drug targets (Tang et al., 2012).  In the orphan 
receptor strategy (tissue extract based approach), ligand screening is carried out by the treatment of 
expressed receptors with crude tissue extracts followed by the identification of the active compound 
(Civelli et al., 1999) by gene knockout.  The putative or known ligand (information based) approach 
makes use of reported outcomes of some substances believed to be potential ligands of 7TM 
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receptors.  These putative ligands are used to fish out suspected oGPCRs which are eventually 
treated with selected ligands (Kotarsky et al., 2003). 
                      
Figure 1.5 A model of the orphan receptor strategy for GPCR deorphanization 
The diagram demonstrates methods for GPCR deorphanization: (a) shows the method of reverse 
pharmacology in which cells expressing orphan GPCRs are treated with purified synthetic or natural 
compounds; and (b) shows the tissue extract based approach (Orphan receptor strategy) in which 
cells expressing orphan receptors are treated with tissue extracts such that subsequent treatment are 
administered with further fractions of the same extract, until a characterized distinct and active 
component is obtained. (C) shows the receptor expression system (e.g. CHO cell, yeast etc.).  
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Responses are measured by second messenger (cAMP, Ca
2+
) level monitoring: adopted from Levoye 
and Jockers (2008).  
 
1.7.3 Factors influencing receptor expression and ligand binding; forms of 
receptor association 
The co-expression of appropriate interacting receptor proteins to enhance either cell surface 
expression or ligand binding (Levoye and Jockers, 2008) has become the Rosetta stone in the 
identification of exact ligands for these orphan receptors.  While the calcitonin receptor-like receptor 
(CRLR) for example, requires receptor activity modulating protein (RAMP) for effective 
translocation to extracellular surface and subsequent binding of ligand (McLatchie et al., 1998), 
some other GPCRs function following their coexpression with other GPCRs based on the suggestion 
that GPCRs are capable of forming higher oligomers or dimers (Bouvier, 2001; Milligan, 2006 ; 
Prinster et al., 2005).  
 
The cell surface translocation of the GABAB1 subunit for example, requires the obligatory co-
expression with GABAB2 subunit, a subunit serving as an orphan 7TM protein lacking a functional 
GABA orthostatic binding site while the GABAB1 subunit is capable of binding to the natural ligand, 
gamma amino butyric acid (Neuhaus et al., 2005; White et al., 1998).  This denotes a classical 
example of an orphan GPCR association with a non-orphan GPCR.  Apart from this form of 
association, oGPCRs are also known to associate with ion channels, a complex formation occurring 
constitutively in the absence of ligand activation e.g. the β2-adrenergic receptor association with the 
L-type calcium channel (Davare et al., 2001) or with the calcium activated potassium channel (Liu et 
al., 2004) and the dopamine D5 receptor association with the GABAA-ligand-gated channel. In 




1.7.4  The concept of constitutive activity and inverse agonism 
The tendency of oGPCRs to remain active in the absence of ligand binding has been explained in a 
number of ways.  One speculation is the existence of an endogenous ligand that is difficult to isolate 
(Seifert and Wenzel-Seifert, 2002).  The inability to isolate an endogenous ligand is tantamount to 
no knowledge of its concentration, making the study of constitutively active GPCRs in such systems 
problematic.  Another is the binding of endogenous inverse agonists which possibly results in the 
masking of the ligand-binding sites (Levoye and Jockers, 2008).  The absence of G protein-coupled 
receptor kinases (GRKs) in yeast needed to regulate inactivation of GPCRs by the prevention of G 
protein coupling (Noble et al., 2003; Penn et al., 2000) possibly explains the high level of receptor 
constitutivity in the yeast system.  
 
More than 60 wild-type GPCRs (>40% of all GPCRs) as of 2001, from the families 1-3 of humans 
and various lab species were found to be constitutively active.  Receptors in these families include 
those for biogenic amines, amino acids, peptides, nucleosides, lipids and proteins (Seifert and 
Wenzel-Seifert, 2002).  Increased constitutive activity has also been identified with various disease-
causing GPCR mutants (in equilibrium) compared to wild-types (Seifert and Wenzel-Seifert, 2002).  
The two-state model of GPCR activation, in attempt to explain GPCR constitutivity, views the TMs 
to be arranged in a clockwise fashion (Bockaert and Pin, 1999) such that the rotation of TMIII 
relative to IV constitute a conformational switch of the TM from an inactive R to an active R* 
isomerization, a state that can occur spontaneously (Seifert and Wenzel-Seifert, 2002) and is 




In this state, the basal activity of G protein and effector systems increase compared to the absence of 
GPCR because the state allows the dissociation of GDP from G proteins.  Apart from blocking the 
effects of agonists, full inverse agonists are those ligands that can maximally stabilize the inactive R 
state and reduce basal GDP/GTP exchange rate, hence, prevent the shift to the active R* state; when 
the rate of exchange favors GTP association with G protein due to increase spontaneity of R switch 
to R*, GPCR constitutive activity increases.  In such a system, neutral agonists (or antagonists), even 
though, are unable to alter the equilibrium between the inactive R and active R* states, they are able 
to block both the inhibitory effects of inverse agonists and the stimulatory effects of agonists (Seifert 
and Wenzel-Seifert, 2002).  This way, receptor constitutivity can be confirmed in the presence of an 
inverse agonist or an agonist.  Agonists, full inverse agonists and antagonists, therefore, form the 
three basic classes of ligands for the characterization of constitutively active GPCRs in a system 
believed to contain an endogenous ligand (Morisset et al., 2000; Wieland et al., 2001).  
 
Of the four subtypes of histamine GPCRs; H1, H2, H3 and H4, two are constitutively active: 
histamine H1 (Leurs et al., 2002) and H3 (Morisset et al., 2000) receptors are GPCRs in which both 
inactive R and active R* states exist in equilibrium such that even in the absence of histamine, these 
receptors remain active.  This way, histamine, an agonist, stabilizes the active state or promotes the 
receptor to remain in the “constitutively active” R* state.  In the absence or presence of an agonist 
(histamine), potential inverse agonists (antihistamines) stabilize the receptor in the inactive R state, 
favoring the association of GDP with G proteins coupling to the receptor rather than GTP.  Since all 
H1 and H3-antihistamines are able to down-regulate such constitutive activity of these two-state 




By coupling to Gq protein subunits, activation of H1-receptors with histamine results in the 
generation of IP3, DAG and Ca
2+
 and subsequent activation of NF-kB (Aoki et al., 1998; Bakker et 
al., 2001; Hu et al., 1999; Leurs et al., 2002), PLD (phospholipase D) and PLA2 (phospholipase A2) 
(Hill et al., 1997; Leurs et al., 2002).  H1-antihistamines successfully down-regulates the levels of 
NF-kB (Leurs et al., 2002) and diminishes its availability and nuclear translocation for the 
transcription of inflammation mediators such as interleukins, hence, establishing the therapeutic 
importance of inverse agonism. 
 
Apart from the use of inverse agonists in the characterization of constitutively active GPCRs, the 
allosteric inverse agonist, Na+ (as NaCl), also stabilizes the R state (Seifert and Wenzel-Seifert, 
2002) by targeting a conserved aspartate residue in TM II of GPCRs (Ceresa and Limbird, 1994) and 
decreases the basal GDP/GTP exchange rate, hence, favors the association of GDP with G proteins 
rather than GTP in the absence of ligands.  The conditions for the success of this include the check 
for the presence of Cl
-
 containing salts (KCl, LiCl and choline chloride).  This way, it is easy to 
eliminate the possibility of the effect of NaCl being due to changes in Cl
–
 or ionic strength (Costa et 
al., 1990; Gierschik et al., 1989; Koski et al., 1982; Wenzel-Seifert et al., 1998). 
  
1.8 The genesis of RNAi  
RNA interference (RNAi) is a step-by-step process resulting in a post-transcriptional gene silencing 
(PTGS) in a sequence-specific manner, in both animals and plants.  The genesis of RNAi was with 
petunias in the early 90’s when the introduction of extra copies of genes (‘transgenes’) that codes for 
deep purple flowers, led to plants with white or patchy flowers (Napoli, 1990; van der Krol et al., 
1990) instead of plants with deep purple flowers.  At this point, it was assumed that a system was 
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activated  that resulted in the silencing of the transgene coding for purple as well as the native gene 
of the plant coding for purple.  The process was accepted as an evolutionarily ancient method of 
genome defense in many organisms against foreign genome.  The mechanism became clear when 
Andrew Fire and Craig Mello published their dsRNA-induced gene silencing in nematode worms 
(Fire et al., 1998) and establishing the mechanism of RNAi using double stranded RNA (dsRNA).  
 
1.8.1  Mechanism of RNAi 
The process begins with the injection or uptake of dsRNA that is homologous in sequence to the 
silenced gene (Fire et al., 1999; Sharp, 2001; Tuschl, 2001).  Prior to the sequence-specific dsRNA-
mediated native mRNA degradation, the previously injected dsRNA has to be cleaved into short 
interfering RNA (siRNA) of 21-22 nucleotides in length, by the enzyme, Dicer (ribonuclease III) 
(Bernstein et al., 2001; Elbashiret al., 2001; Hamilton and Baulcombe, 1999; Zamore et al., 2000).  
The sense strand (strand with same nucleotides as target gene) of the siRNA (resulting from Dicer 
cleavage of dsRNA) is removed from the antisense (strand complementary to the target gene).  The 
protein capable of doing the distinction between the two strands of siRNA is the RNA-induced 
Silencing Complex (RISC).  Once the sense RNA is isolated from the antisense, it is destroyed.  The 
remaining antisense strand then serves as a guide to the RISC protein complex, leading them to 
locate mRNA of target genes to destroy them.  This is the case in fruit flies and mammals where the 
antisense strand gets incorporated into the RISC to target a complementary mRNA by repeated 
cycles of degradation of specific mRNA; hence, no protein is translated.  This way, the gene from 
which such mRNA is transcribed is unable to get expressed into protein; the gene is therefore, said to 




In worms and plants on the other hand, the antisense strand of the resulting siRNA might get bound 
by an RNA-dependent RNA polymerase enzyme (RdRP), forming a complex which pair with a 
complementary mRNA to synthesize a longer dsRNA.  This way, numerous copies of dsRNA are 
made to be cleaved (by a Dicer) into yet, increased copies of siRNA, whose antisense strands will be 
specific to different sequences on the same mRNA strand. 
 
1.8.2  Applications  
With the advent of RNAi, the classical genetic analysis (‘forward genetic analysis’) of gene function 
has taken a different turn called ‘reverse genetic analysis’ which begins with knocking out 
(suppression by RNAi as an easier alternative) a specific gene and identifying its function.  An 
important breakthrough with RNAi was its application in the elucidation of genes involved in 
cholesterol metabolism and heart formation in fruit flies.  Genomic libraries of 12,000 different 
dsRNAs were used to screen C. elegans for genes mediating phenotypes such as obesity and ageing 
(Novina and Phillip, 2004).  
 
While the silencing of unc-22 gene of C. elegans resulted in a phenotype of strong twitchers, the 
silencing of the unc-54 gene resulted in paralysis (Fire et al., 1998).  Even though the dsRNA was 
proven to be more effective in producing interference compared to either strands individually (Fire et 
al., 1998), the large size of the dsRNA makes it an obstacle for uptake by some cells such as Human 
cells in vitro, and are killed mostly by these dsRNAs.  This problem was addressed by the use of 
chemically synthesized short interfering RNA (siRNA; 21-22bp) (Elbashir et al., 2001).  The 
functions of approximately 8000 genes of the human genome were elucidated using siRNA.  The 




1.8.3  Methods of RNAi and relative potencies 
The dsRNA molecule being directed towards target genes to induce suppression can be delivered by 
injection, soaking of test organism in a solution of dsRNA or by feeding them bacteria expressing 
the dsRNA.  The injection of dsRNA into C. elegans resulted in potent and specific interference 
which were evident in the injected worm as well as its progeny (Fire et al., 1998).  The ingestion of 
dsRNA expressing bacteria is as effective as the injection of dsRNA for RNAi (Kamath et al., 2000).  
 
Feeding has some merits over other forms of dsRNA delivery.  First, the process is less labor-
intensive, hence, could be carried out on large number of worms when large number of genes needed 
to be screened.  In addition to being able to draw representative statistical conclusion from large 
sample space, it allows whole genome screen within a relatively short period of time (Kamath et al., 
2000).  Second, the cost of making dsRNA-expressing bacteria for high-throughput genome-wide 
RNAi screens is relatively low compared to making dsRNA for injection (Fire et al., 2000) or 
soaking.  The bacterial expressing a specific gene becomes a durable reagent because it could be 
reused to reproduce an RNAi phenotype at a cheaper cost.  Also, the interference effect due to 
feeding can be titrated to reveal an array of hypomorphic phenotypes due to the absence of any gene 
(Kamath et al., 2000).  
 
1.8.4  dsRNA-mediated RNAi in mammalian cultures 
Even though dsRNA-mediated gene silencing was successful in insect cell lines and worms, the 
same molecule was unable to induce potent and specific gene silencing in mammalian cells such as 
Human Embryonic Kidney cells (293), Chinese Hamster Ovary (CHO-K1), Syrian Baby Hamster 
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Kidney (BHK-21) and Mouse fibroblast (NIH/3T3) (Caplen et al., 2000; Clemens et al., 2000).  The 
application of dsRNA varying in size between 38 and 1,662 base pairs were realized to have elicited 
a non-specific interferon response such that dsRNA> 30bp binds and activate the protein kinase PKR 
(Manche et al., 1992) and a synthetase (2,5-oligoadenylate synthetase, 2, 5-AS) (Minks et al., 1979).  
 
The kinase then phosphorylates the translation initiation factors: elF2α and the activated 2, 5 –AS, 
resulting in non-specific mRNA degradation by the ribonuclease, 2, 5-oligoadenylate-activated 
ribonuclease L, hence, stalls translation.  In order to bypass this interferon response, short interfering 
RNA (siRNA) with overhanging 3’ ends (Base-paired) of 22- nucleotides in length, were used to 
mediate sequence specific mRNA degradation (Elbashir et al., 2001) resulting in siRNA-mediated 
gene suppression in mammalian cells. 
 
1.8.5  Planarians as promising research models; models for RNAi studies 
Planarians are free-living flatworms in the phylum Platyhelminthes that live mostly in free flowing 
streams.  They belong to the group, Lophotrochozoa, a less studied group of animals that is sister to 
the Ecdysozoa (e.g. Drosophila and Caenorhabditis elegans) and the Deuterostomes (e.g. non-
mammalian and mammalian vertebrates) (Robb et al., 2008).  They possess a synaptic nervous 
system with cranial ganglia often described as a primitive brain (Abbot and Wong, 2008).  They 
have the ability to regenerate body parts including the central nervous system (CNS), made possible 
by the possession of a reservoir of adult stem cells (Gentile et al., 2011) called neoblast.  In effect, 
they are close to being “immortal cell lines”.  Supported by new post genomic technologies and 
established biological readout systems, the planarian system has become one of the easily available 




First, they can be grown to large populations and maintenance is cost effective.  Second, they are 
easily amenable to RNAi treatments; RNAi can be carried out in them by feeding, injection, or by 
soaking.  Third, they develop phenotypes rapidly.  Fourth, some proteins in planaria bear significant 
similarities to human proteins.  Since most planarian genomic regions were found to have significant 
similarity to human disease-related genes as listed in the paper by Gentile (Gentile et al., 2011), 
RNAi studies in these can reveal the functions of both known and unknown genes possibly involved 
in the development and the diseases of man.  Also, many planarian genes are homologous to genes 
in most human parasites such as Schistosoma mansoni.  The studies and eradication of these human 
parasites becomes relatively easier having established some degree of functionality of their 
homologous genes in these planarians. 
 
1.8.6  Promoting planarian research 
An aspect of planaria most studied is its impressive regenerative capabilities.  As early as the 19th 
century, Thomas Hunt and Harriet Randolph defined the minimal size of a planarian fragment 
capable of regeneration to be 1/279th of the intact animal’s volume (Morgan, 1901).  The use of 
planarian in current time as a model organism is on the increase.  In order to drive research in this 
area, the 1st International Meeting on Planarian Biology (IMPB) was held in May, 2010 in Münster, 
Germany, where EuroPlanNet (www.europlannet.org) was lunched as a means to overcoming 
existing technical limitation in planarian research.  It aimed to create a common database that 
manages integrated genomic and transcriptomic datasets.  It will also provide a common 
infrastructures and a student exchange programme (Gentile et al., 2011).  The aim is to promote the 




1.8.7  5-HT in flatworms 
It’s been known that 5-HT stimulates intact flatworm motility in vitro (Boyle et al., 2000; Hillman 
and Senft, 1973; Holmes and Fairweather, 1984; Maule et al., 1989; Mellin et al., 1983; Sukhdeo et 
al., 1984) and also induces contraction of muscle strips and of cut worm preparations (Pax et al., 
1984; Thompson and Mettrick, 1989).  Prior to RNAi experiments later in the following chapters, 
this dissertation verified flatworm species variations in their response to serotonin.  
 
Table 1.4  Mammalian serotonin receptors and G protein-coupling 
 
 
1.8.7.1  RNAi in Schmidtea mediterranea 
Schmidtea mediterranea (Smed) has of late, gained its place as a model in biomedical research partly 
because its genome has been well curated in addition to the possession of such reservoir of 
pluripotent or somatic stem cells (Gentile et al., 2011; Handberg-Thorsager et al., 2008) as any other 
planarian.  Depending on environmental conditions, Smed reproduce either sexually or by fission.  It 
has a diploid genome of about 800 Mb and is approximately 0.1-2 cm in size (Gentile et al., 2011).  
The genome is distributed on four chromosomes making up 30,000 predicted genes (Cantarel et al., 
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2008).  Gene-specific knockdown in planarians using RNA interference (RNAi) resulted in the 
identification of several genes (Newmark  et al., 2003; Alvarado and Newmark, 1999). 
  
The netrin family of proteins (involved in brain regeneration) acting as chemoattractants or 
chemorepellents in Smed subjected to RNAi, resulted in a disorganized phenotype of axonal 
projections, hence, their function elucidated to be axon guidance in the process of regeneration 
(Cebrià and Newmark, 2005).  The Fibroblast growth Factor Receptor (FGFR)-related protein, Nou-
darake (Ndk), expressed in the head region of the animal relevant for positional identity of the brain, 
subjected to RNAi, resulted in ectopic brain formation throughout the worm suggesting ndk 
determines and ensures the restriction of the brain to the head region (Cebrià and Newmark, 2005). 
 
1.8.7.2  RNAi in Girardia tigrina 
Even though the genome (sequencing underway) of the planarian species, Girardia tigrina, is yet to 
be available in its full and annotated form, it has been exploited in other respects; by blind and 
degenerate amplification of putative genes of planarian origin in studies targeting specific genes; in 
pharmacological and behavioural studies; and in an array of regenerative studies in the presence of 
exogenous transmitters.  RNAi was applied in G. tigrina in the studies of HSP-related genes in the 
dynamics of neoblasts.  The RNAi-mediated silencing of either of the two neoblast-specific HSP 
members, Djhsp60 (HSP60 gene family) and Djmot (HSP70 gene family), known to be responsible 
for protection of pluripotent cell system (neoblast) of planarians, resulted in growth arrest in 





1.8.7.3  RNAi in Tetrahymena thermophila  
Ciliated protozoans are unicellular eukaryotes most of which have a two nuclear system, somatic 
macronucleus and a germline micronucleus.  Tetrahymena is one of such organisms.  Both nuclei of 
Tetrahymena originate from the same zygotic nucleus formed during sexual reproduction (Yao and 
Ju-Lan, 2005).  While its macronucleus is responsible for most gene expression functions, the 
micronucleus endures a faithful genome transmission.  RNAi has been well established in the ciliate 
Tetrahymena thermophila and known to have unique consequences on Tetrahymena genome 
different from RNAi consequences in all other organisms.  
 
Instead of causing post-translational gene modification or PTGS, the dsRNA processed into siRNA 
leads to DNA elimination in Tetrahymena (Grewal and Moazed, 2003; Volpe et al., 2002; Yao and 
Ju-Lan, 2005), hence, an RNA-guided DNA deletion phenomenon.  Even though the exact 
mechanism by which siRNA recognizes the genomic DNA is not yet understood, the discovery 
supports the contention, that siRNA can specifically recognize DNA sequences.  Most importantly, 
the injection of dsRNA into conjugating cells is enough to induce specific DNA deletion in 
Tetrahymena (Yao et al., 2003), hence, no protein expression.  Base pairing was thought to be RNA-
DNA pairing through the formation of a d-loop (Yao and Ju-Lan, 2005).  The phenomenon of 
macronuclear or micronuclear reorganization in Tetrahymena during vegetative reproduction or 
conjugation is thought to be governed by this RNAi-guided DNA deletion.  
 
The dsRNA is transcribed from most deletion elements in the micro or macronucleus and cleaved 
into sRNA (a species of small RNA, 26 to 28 nucleotides in length) just as in other systems 
involving a Tetrahymena dicer-like gene DCL1 (Mochizuki and Gorovsky, 2005).  Finally, the 
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sRNA becomes the effector RNA in a RISC complex and guides it to genomic regions containing 
the corresponding sequences where the target DNA is deleted, by a yet-unknown mechanism.  This 
RNAi mediated DNA deletion is evidenced in the fact that silencing of DCL1 or an argonaute 
protein gene, TWI1, resulted in the blockage of conjugation and DNA deletion in Tetrahymena 
Intraflagellar Transport, IFT, a motor for intraciliary transport in Tetrahymena (Awan et al, 2004; 
Awan et al., 2009), mediated by the kinesin-2 superfamily becomes inhibited when kin5 was 







Figure 1.6 A model of the mechanism of double-stranded RNA-induced gene silencing 
 RNAi begins by the introduction of dsRNA, shRNA, internal repeats or transgenes across the 
plasma membrane of cells.  Within the cell, these molecules are recognized and cleaved by the Dicer 
enzyme to produce siRNA (short interfering RNA of 21-22 nucleotides in length).  5′ends are 
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maintained by phosphorylation by a putative kinase.  While some of the resulting siRNAs are 
thought to target de novo cytosine methylation events needed for heterochromatin formation 
(Onodera et al., 2005) (1), in the presence of RNA-dependent RNA polymerase (RdRP) in worms 
and plants, the antisense strand of other resulting siRNA might get bound by RdRP, forming a 
complex capable of pairing with a complementary mRNA to synthesize a longer dsRNA which is in 
turn cleaved by a Dicer into numerous copies of siRNA needed for systemic spread (2) and RISC 
loading.  The siRNAs are then loaded onto RISC complexes equipped with a helicase which 
unwinds the siRNAs such that the antisense strands in the RISC guides the complex to target 
mRNAs and its cleavage.  The numerous antisense components of resulting siRNA will be specific 
to different sequences on the same mRNA strand.  Figure modified from Agrawal et al., 2003; Smith 
et al., 2012; Whitehead et al., 2009. 
 
1.8.7.4  RNAi, pitfalls 
The natural phenomenon of RNAi, however, has some limitations in its occurrence in some species 
of organisms.  Its occurrence is dependent on the existence of the enzyme, RNA-dependent RNA 
polymerase (RdRP), needed by the antisense strand of siRNA to initiate the amplification of copies 
of more dsRNA (Novina and Phillip, 2004) enough to “span the genome”.  In other words, it allows 
RNAi-mediated gene silencing to spread among non-reproductive tissues by cell-to-cell transfer of 
dsRNA in plants for example.  In an attempt to apply RNAi for disease therapy, the problem of 
delivery arises, requiring the difficult task of necessary delivery of short dsRNA into specific organs.  
Another problem of RNAi is the inability to efficiently silence all genes; hence, an RNAi-based 
screen might evade very important genes.  However, it is currently an indispensable complement to 




1.9 General objectives 
To pursue and characterize biogenic amine-sensitive GPCRs in two important phyla of organisms in 
which biogenic amines are indispensable.  Previous research identified the relevance of 
catecholamines and the monoamine, serotonin, in the phyla of Protozoans and Platyhelminthes 
respectively.  However, the mode of reception of these amines hasn’t been largely documented.  
With the current documentation of at least 29 gene homologs of flatworms found in very crucial 
metabolic disease states of humans and in the native state of important human parasites, and with 
protozoans being causative agents for a myriad of infectious diseases that are adamant to treatments, 
it is appropriate first to pursue at the grass roots, the functions of biomolecules that governs the 
metabolic and physiological processes of these organisms. 
Objective 1 To use RNAi coupled with heterologous expression in the deorphanization of 
protozoan catecholamine responsive GPCR relevant in phagocytic pathways of Tetrahymena 
thermophila. 
Objective 2 To use an established loss-of-function GPCR deorphanization protocol coupled with 
G protein transductional coupling determination and the monitoring of phenotypes in the 
deorphanization of serotonergic GPCRs in two species of planaria; Schmidtea mediterranea and 









CHAPTER 2 Catecholamine activation of a putative G protein-
couple receptor involved in bacterial engulfment by the protozoan 
Tetrahymena 
 
A paper to be submitted 
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2.1 Abstract 
Catecholamines are ubiquitous signaling molecules produced and/or recognized by a number of 
organisms ranging from mammals to plants to protozoa to bacteria.  In the protozoan Tetrahymena, 
catecholamines stimulate the phagocytosis of particulates.  In other eukaryotes, catecholamines 
modulate physiologic functions by interacting with membrane-spanning GPCRs on cell surfaces.  In 
this study we investigated three putative Tetrahymena GPCRs as transducers of catecholamine-
induced bacterial engulfment, a process that is important for both protozoa and bacteria, which may 
be analogous to the phagocytosis of particulates.  RNAi-based studies revealed that knock-down of 
one of these GPCRs caused diminished bacterial engulfment by Tetrahymena.  This protein was 
expressed in an auxotrophic yeast system that enables the deorphanization of GPCRs.  The 
catecholamines epinephrine, norepinephrine, and dopamine activated the receptor in the 
heterologous expression system while serotonin blocked the activation of this receptor designated as 
TetEPI-1.  Furthermore, epinephrine was shown to stimulate the ability of Tetrahymena to engulf 
bacteria in an axenic culture and this phenomenon was inhibited by RNAi knock-down of TetEPI-1 
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and by serotonin.  These data demonstrate that TetEPI-1 is an atypical catecholamine-recognizing 




Tetrahymena is a free-living protozoan exhibiting phenotypes also observed in pathogenic protozoa, e.g., the 
engulfment of bacteria (Hirata et al., 2007).  Pathogenic protozoa are the causative agents for a large number 
of infectious diseases that are refractory to treatments, thus the identification of druggable targets is highly 
desired.  Nearly 50% of all marketed drugs target GPCRs (Flower, 1999; Wise et al., 2002), seven 
transmembrane-spanning receptors that are located on cellular surfaces and serve as transducers of 
extracellular stimuli into intracellular signals. 
 
Lampert et al. (2011) identified a Tetrahymena GPCR and presented evidence for nine GPCR-encoding genes 
in the Tetrahymena database.  Another group determined that Tetrahymena phagocytosis apparently involves 
G proteins that couple to GPCRs (Renaud et al., 1995).  Candidate ligands for Tetrahymena GPCRs include 
catecholamines since Quiñones-Maldonado et al. (1987) demonstrated that catecholamines stimulate 
phagocytosis in Tetrahymena and since catecholamines are ubiquitous activators of GPCRs in multi-cellular 
eukaryotes.  Additionally, epinephrine and dopamine have been isolated from Tetrahymena (Janakidevi et al., 
1966) suggesting that these molecules may be intercellular or autocrine-like messengers that coordinate 
protozoal activity.  All together, evidence suggests an associated between phagocytosis, catecholamines, and a 
GPCR(s) in Tetrahymena. 
 
Our laboratory has established that protozoal engulfment of bacteria, which may be analogous to phagocytosis 
of particulates, is an important phenomenon for bacterial virulence and protozoan physiology (Rasmussen et 
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al., 2005; McCuddin et al., 2006; Carlson et al., 2007; Brewer et al., 2011).  The goal of this project was to 
explore GPCRs that facilitate bacterial engulfment by Tetrahymena.  In this study, we targeted three putative 
GPCRs in Tetrahymena and used RNAi to determine if one of these GPCRs is involved in bacterial 
engulfment by Tetrahymena.  Because of potential shortcomings of using RNAi in a protozoan with 
dimorphic nuclei, we also used a heterologous yeast expression system to examine one of the candidate 
GPCRs.  Additional studies evaluated the role of this receptor in catecholamine-activated Tetrahymena 
engulfment of bacteria and it is hence referred to as TetEPI-1, based on its recognition of epinephrine. 
 
2.3   Materials and methods 
2.3.1  Tetrahymena cultures  
Tetrahymena thermophilia was obtained from ATCC and axenically grown in the recommended ATCC 
medium (5.0 g/L proteose peptone, 5.0 g/L tryptone, and 0.2 g/L K2HPO4) at 25
o
C.  Media was replaced 
every four days and cells were diluted 1:14 in fresh media.   
 
2.3.2  RNAi experiments  
A preliminary GenBank database search identified three putative GPCR genes in Tetrahymena 
[XM_001009792.2 (TetEPI-1), XM_001027519.2, and XM_001010055.2].  siRNA was designed, 
using the Invitrogen webportal, to silence expression of these three genes in Tetrahymena.  The 
sequences GAGATTACTACTAATAGCCTCTCTT, GCTGATTCATTTAATAGCCTTGCTT, and 
TGGCTCA-GTGTAAGTGACTTAATAT were deemed to be appropriate targets for the three 
putative GPCRs.  A random sequence (CTGACGACAGTTGCATAAAGC) was used as a control.  
Tetrahymena thermophila were grown in 5mL of media to reach confluency (3 x 10
4
 cells/mL), and 
then were harvested by centrifugation at 3,000 x g for 10 min.  The pellet was washed twice in 15 
mL of deionized water and resuspended in 200L of deionized water.  These cells were then 
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electroporated (0.2cm electrode gap, 10F, and 5 milliseconds) with 0.5nM siRNA.  Cells were 
assessed for bacterial engulfment at 24 hours after electroporation as described previously (Carlson 
et al., 2007).  Briefly, bacteria were incubated with the protozoa and then Tetrahymena cells were 
centrifuged at 4,000 x g for 5 minutes.  Cells were resuspended in 1mL of Luria-Bertani (LB) broth 
containing 108 colony-forming units of a strain of Salmonella that is engulfed by Tetrahymena and 
survives engulfment (Carlson et al., 2007).  Non-engulfed bacteria were then killed with florfenicol 
(300g/mL) and protozoa were lysed with bead-beating.  Lysates were recovered and plated on agar 
used for enumeration of bacteria engulfed. 
 
2.3.3  RT-PCR experiments  
Protozoa were subjected to semi-quantitative evaluation of TetEPI-1 expression.  RT-PCR was 
performed using oligonucleotide primers specific to TetEPI-1 transcripts (forward, 5’ATGGAC-
CAATCATTTGGAAATCAA3’; reverse, 5’TCAAGTTAGATTTATTTCACGTGAAT3’).  RNA 
was quantitated (GE Nanovue) and standardized between groups and procedures employed were 
similar to those recently described for semi-quantitation of an unrelated transcript (Carlson et al., 
2007).  Specifically, 1198bp amplicons were resolved using agarose gel electrophoresis and the 
agarose gel-based visual appearance of amplicons was evaluated after every five successive cycles. 
  
2.3.4  Creation of the gene encoding TetEPI-1 
RNAi studies identified one of the putative GPCRs [XM_001009792.2 (i.e., TetEPI-1)] as a determinant of 
bacterial engulfment.  In order to deorphanize this receptor in the yeast heterologous expression system, its 
gene must be cloned into a yeast expression vector.  Since Tetrahymena genes have read-through stop codons 
encoding glutamine residues (Adachi and Cavalcanti, 2009), the gene encoding TetEPI-1 was synthesized 
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(GeneScript) whereby the 13 read-through stops codons (TAA or TAG) were exchanged for glutamine 
codons (CAA or CAG).  Codons were also optimized for expression in yeast. 
 
2.3.5 Creation of the yeast expression vector encoding TetEPI-1 
 The synthetic TetEPI-1 gene was PCR-amplified with forward 
(5’GCCATACCATGGACCAATCATTTGGAAATCAA3’)  
and reverse (5’GCCATAGGATCCTCAAGTTAGATTTATTTCACGTGAAT3’) primers which 
included filler sequences (underlined) and the restriction sites NcoI and BamHI (italicized) 
incorporated into the 5’ and 3’ ends of the amplicon, respectively.  Purified amplicons and the 
linearized yeast expression vector Cp4258, which bears a leucine prototrophic marker (Kimber et al., 
2009; Wang et al., 2006), were co-digested with NcoI and BamHI restriction endonucleases (New 
England Biolabs).  The digested vector and amplicons were ligated with T4 DNA ligase (New 
England Biolabs) and the resulting plasmid was transformed into E. coli and individual clones were 
selected and grown in LB broth overnight.  Plasmid DNA was purified using HiSpeed Plasmid Mini 
Kit (QIAGEN) and inserts were verified using PCR and then sequenced to confirm cDNA 
orientation and fidelity. 
 
2.3.6  Transformation of yeast with the TetEPI-1 expression vector 
Saccharomyces cerevisiae strain CY 19043 (J. Broach, Princeton University, USA) was used as the 
yeast recipient since these cells are leucine/histidine auxotrophs but exhibit a histidine prototrophic 
phenotype upon GPCR activation even for exogenous receptors (Kimber et al., 2009; Wang et al., 
2006).  Non-transformed CY 19043 yeast were grown in YPD media supplemented with all essential 
amino acids.  Cells at mid-log phase (OD600 equal to 0.3 to 0.5) were transformed with 1g of 
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Cp4258/TetEPI-1 construct or 1g empty vector (mock transformants) in the presence of 200g 
salmon sperm DNA (Invitrogen) and 0.1M LiAc (Sigma-Aldrich).  Transformed yeast were 
incubated at 30oC and then heat shocked at 42oC for 15 minutes.  Cells were placed on leucine-
deficient media [1x YNB (Difco), 1x yeast synthetic dropout medium supplement without leucine 
(Sigma), 10mM ammonium sulfate (Sigma), and 50% glucose] to select for transformation of 
Cp4258 containing the TetEPI-1 insert.  Transformants were verified by isolating plasmids 
(Promega) and PCR-based detection of the TetEPI-1 insert and its proper orientation.  
 
2.3.7  Ligand assays in yeast transformants 
 A volume of 3mL leucine-deficient media was inoculated with yeast expressing TetEPI-1, or the mock 
controls, and grown at 30
o
C to an OD600 equal to one.  Cells were washed three times with leucine/histidine 
deficient medium [1x YNB (Difco), 1x yeast synthetic drop out medium supplement lacking leucine and 
histidine (Sigma), 10mM ammonium sulfate, 50% glucose, 50mM 4-morpholinepropanesulfonic acid, pH 
6.8], then resuspended in 1mL leucine/histidine-deficient media to a density of 15–20 cells/µL.  
Approximately 3,000 cells were added to each well of 96-well plates containing the same medium along with 
2mM of test agonists in a total volume of 200L.  Cells were grown at 30oC for approximately 24 hours after 
which growth was measured spectrophotometrically at OD600.  All agonists used in the study were obtained 
from Sigma-Aldrich.  Mock transformants were used as controls. 
 
2.3.8  Epinephrine and Tetrahymena engulfment of bacteria 
Tetrahymena thermophila cells were centrifuged at 4,000 x g for 5 minutes and cells were 
resuspended in 1mL of LB broth containing 108 colony-forming units of a strain of Salmonella that 
is engulfed by Tetrahymena and survives engulfment (Carlson et al., 2007) or a strain whose growth 
is not stimulated in the presence of catecholamines (McCuddin et al., 2008).  Various concentrations 
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(0.1-200M) of epinephrine, norepinephrine, dopamine, and serotonin were added and cells were 
incubated at room temperature for additional 1-16 hours.  Percent engulfment was then determined 
as described previously by killing the extracellular (non-engulfed) bacteria, lysing the protozoa, and 
enumerating the bacteria liberated from the protozoa (Carlson et al., 2007). 
 
2.3.9  Statistical analyses 
Statistical comparisons were made using ANOVA using Bonferonni’s correction for multiple 
comparisons.  Prizm 5.0 was the software used. 
 
2.4 Results  
2.4.1  RNAi-based identification of a GPCR involved in bacterial engulfment by 
Tetrahymena 
Our preliminary database query identified three Tetrahymena genes encoding putative GPCRs.  In 
order to assess the association of these GPCRs with bacterial engulfment, we knocked-down 
receptor expression with siRNA and then evaluated bacterial engulfment in Tetrahymena.  As shown 
in Fig. 2.1, bacterial engulfment was significantly hampered in Tetrahymena electroporated with one 
of the siRNA (accession number XM001009792.2).  Semi-quantitative RT-PCR experiments 
revealed that the siRNA dampened expression of this gene.  Fig. 2.2 demonstrates the viability of 







2.4.2  Deorphanization of the Tetrahymena GPCR involved in bacterial engulfment 
Studies presented in Fig. 2.1 identified a putative GPCR involved in bacterial engulfment by 
Tetrahymena.  In order to deorphanize this receptor, we expressed its codon-optimized cDNA in a 
yeast heterologous expression system that exploits a histidine prototrophic phenotype upon GPCR 
activation by a cognate ligand (Kimber et al., 2009; Wang et al., 2006).  Previous studies associated 
catecholamine responsiveness in Tetrahymena (Quiñones-Maldonado et al., 1987) thus yeast 
transformants were exposed to various catecholamines and histidine prototrophism was measured.  
Control yeast transformants were grown in histidine-deficient media in the absence of a ligand.  As 
shown in Fig. 2.3, epinephrine, norepinephrine, and dopamine elicited moderate increases in yeast 
growth in the transformants (receptor expression verified by RT-PCR, not shown).  Interestingly, 
serotonin (a non-catecholamine/biogenic monoamine) inhibited the epinephrine-mediated growth of 
the yeast and it displayed mild inverse agonism of basal receptor activity.  Xylazine, an 2-
adrenergic receptor agonist, did not stimulate histidine prototrophism in the yeast.  
 
2.4.3  Epinephrine activation of bacterial engulfment by Tetrahymena 
To confirm the biologic relevance of TetEPI-1 for Tetrahymena, we incubated bacteria with an 
axenic culture of Tetrahymena exposed to concentrations of epinephrine that stimulated 
phagocytosis as per previous studies (Quiñones-Maldonado et al., 1987).  Additionally, we incubated 
bacteria with TetEPI-1 knock-down Tetrahymena exposed to concentrations of epinephrine.  
Bacterial engulfment was then quantitated in these co-cultures.  Additionally, serotonin was used in 
place of epinephrine or with epinephrine.  As shown in Figs. 2.4 and 2.5, bacterial engulfment was 
stimulated by catecholamines in a concentration-dependent manner (EC50= 9-17.5M) and a time-
dependent manner (time to maximal effect ~2hrs).  Epinephrine was only able to partially restore 
54 
 
bacterial engulfment in TetEPI-1 knock-down Tetrahymena.  Serotonin inhibited the effect of 
epinephrine on phagocytosis (IC50= 32M) and it inhibited phagocytosis in the absence of 
epinephrine, suggesting that it has some inverse agonist activity on TetEPI-1. 
 
2.5 Discussion 
GPCRs are important membrane proteins because they constitute the largest and most diverse groups 
of receptor proteins (Teller et al., 2001).  With the establishment of GPCRs as targets of numerous 
drugs, the search for GPCRs has been on the increase.  Although Tetrahymena has been established 
as an important model protozoan, there is little information on GPCRs in this organism (Husson et 
al., 2007; Lampert et al., 2011) and there has been debate regarding their existence in this protozoan 
(Renaud et al., 1991).  Herein, the process of reverse pharmacology was used in the deorphanization 
of the TetEPI-1 GPCR in Tetrahymena as an adrenergic-type receptor that is responsive to 
catecholamines, and this response is involved in bacterial engulfment.  This receptor is likely a 
GPCR given its ability to stimulate histidine prototrophism in a yeast heterologous expression in 
which G proteins govern de novo synthesis of histidine following ligand occupancy of a GPCR.  
 
Previous studies have established the production of catecholamines by Tetrahymena (Blum et al., 
1967; Janakidevi et al., 1966), suggesting that these molecules may serve as intercellular or 
autocrine-like messengers.  However, the mode of catecholamine reception has not been 
demonstrated in Tetrahymena.  In the yeast GPCR expression system, the stimulatory effect of the 
catecholamines on TetEPI-1 was moderate yet consistent.  Epinephrine was the most potent of the 
catecholamines examined, although the potency measurements are reflective of the yeast system that 




Since catecholamine biology in Tetrahymena is biochemically unique, a direct comparison of 
adrenergic receptor subtypes among eukaryotes is difficult especially considering that TetEPI-1 was 
expressed in yeast for these studies.  Additionally, anabolic and catabolic enzymes govern 
catecholamine isoforms in Tetrahymena (Nomura et al., 1998) although application of exogenous 
epinephrine led to a stimulatory effect on bacterial engulfment by Tetrahymena.  
 
Catecholamine GPCRs have been categorized based on affinities for the ligands.  Epinephrine and 
norepinephrine exhibit high affinity binding to α1-adrenergic receptors with modest affinities for α2- 
and β-adrenergic receptors (Kroeze et al., 2003).  Preliminary data from our studies demonstrated 
that dobutamine, a synthetic catecholamine with a strong affinity for both β1- and β2-adrenergic 
receptors (Overgaard and Dzavík, 2008), did not activate TetEPI-1 (data not shown).  TetEPI-1 
could be best described as an α1-adrenergic receptor but this categorization is currently arbitrary 
since protozoan receptors will likely have their own classifications as more receptors are 
characterized.  This is especially true given the serotonin-mediated antagonism and inverse agonism 
of TetEPI-1.   
 
Further studies will be devoted to determining the full array of adrenergic agonists and antagonists 
of TetEPI-1.  It is of note that the activity of this receptor is not completely aligned with a previous 
study (Quiñones-Maldonado et al., 1987) that identified catecholamine-mediated phagocytosis of 
particulates.  This previous study determined that phagocytosis is activated by lower concentrations 
of either catecholamine receptor agonists or serotonin receptor antagonists, contrary to the findings 




In conclusion, we have identified and characterized, for the first time, a unique catecholamine-
responsive GPCR in the protozoan Tetrahymena thermophilia.  The identification of this receptor 
will serve as model therapeutic target for selectively inhibiting pathogenic protozoa.  We have 
named this unique receptor TetEPI-1, accounting for its recognition of epinephrine. 
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Figure 2.1  Bacterial engulfment and TetEPI-1 expression by Tetrahymena electroporated with 
RNAi corresponding to putative GPCR genes   
A preliminary database search identified three putative GPCR-encoding genes (accession numbers provided 
in the x-axis) in Tetrahymena and siRNA was designed based on these sequences.  Bacterial engulfment 
(average number of bacteria engulfed per cell) was determined after electroporation with siRNAs.  Random 
RNAi and mock transformants served as controls.  Data presented are the mean + sem for three independent 
experiments performed in triplicate.   *p<0.05 versus the rest of the data.  Increasing the amount of siRNA 
100-fold did not change bacterial engulfment data (not shown).  Numbers above each column represent the 
















Figure 2.2  Effect of TetEPI-1 gene silencing in Tetrahymena 
Protozoa were electroporated with siRNA (0.5nM) and cell viability was evaluated microscopically.  At 16 
hours post-electroporation, cell viability was indistinguishable between mock-electroporated and 
electroporated Tetrahymena, regardless of the siRNA.  Magnification = 200X 





Figure 2.3  Catecholamine-mediated activation of histidine prototrophism in yeast expressing 
TetEPI-1   
Yeast transformants were exposed to 2mM of the various ligands and yeast growth was measured 
spectrophotometrically at OD600.  To determine background growth, yeast were exposed to ligand-free media 
lacking the two amino acids (vehicle).  Growth is quantitated as compared to growth observed in mock 
tranformants.  Data presented are the mean + sem for three independent experiments performed in triplicate.  
*p<0.05 versus vehicle.  These effects dissipate when a protease is co-incubated with the ligand (data not 








Figure 2.4  Concentration-response curves for bacterial engulfment of Tetrahymena exposed to 
various catecholamines or serotonin   
The effect of epinephrine on bacterial engulfment was also assessed in Tetrahymena in which TetEPI-1 
expression was knocked down by RNAi as per Fig. 1.  Bacteria were incubated with Tetrahymena and then 
enumerated after recovery from lysed protozoa.  Data presented are the means for three independent 




Figure 2.5  Time-dependent assay of bacterial engulfment of Tetrahymena exposed to various 
catecholamines or serotonin [50uM] 
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The effect of epinephrine on bacterial engulfment was also assessed in Tetrahymena in which TetEPI-1 
expression was knocked down by RNAi as per Figs. 1 and 2.  Bacteria were incubated with Tetrahymena and 
then enumerated after recovery from lysed protozoa.  Data presented are the means for three independent 
experiments performed in triplicate.  Similar results (not shown) were observed using a strain of Salmonella 



























CHAPTER 3  Identification and functional characterization of 
serotonin GPCRs mediating flatworm motility 
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3.1 Abstract  
Planarian flatworms have been rediscovered as important animal models in neuropharmacology and 
well characterized for developmental biology and regenerative research.  With most drugs targeting 
GPCRs, receptor mediated movement studies in planarians has evolved as a fast growing area of 
science which can be harnessed into parasite studies to hamper parasite physiology based on 
characterized receptor homologs shared with these planarians.  In a previous study of serotonin 
pharmacology in the species of planaria; Schmidtea mediterranea and Girardia tigrina, we’ve 
established the ability to silence putative 5HT-receptors and also a neuropeptide receptor using RNA 
interference.  Here, we’ve investigated putative 5-HT4 receptors that mediate cAMP stimulation and 
its consequences on motility of planarians due to stimulation by various serotonergic receptor 
agonists.  Even though its actions are normally inhibitory at synapses, serotonin demonstrates an 
excitatory effect on S. mediterranea motility but   had moderate inhibitory effect on G. tigrina 
motility.  Suppression of both putative 5HT receptors in S. mediterranea resulted in significant 
decrease in worm motility.  Suppression of the putative 5-HT4 receptor suspected to mediate 
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serotonin-induced moderate decrease in G. tigrina motility, resulted in significant decrease in cAMP 
stimulation (P<0.0001) by serotonin.  Forskolin, a potent activator of adenylate cyclase mimics the 
moderate inhibitory effect of serotonin on G. tigrina motility with significant effects at 10µM.  
Serotonin significantly antagonized the calcium-induced increase in G. tigrina motility, further 
supporting the moderate inhibitory effect of serotonin in this species of planaria.  These data 
demonstrate the relevance of these putative GPCRs in the motility of flatworms.  Based on receptor 
homology, transductional coupling and pharmacology of these putative receptors compared to 
characterized 5HT4 GPCRs, we conclude these putative GPCRs could be classified as planarian 
5HT4 GPCRs, namely Dtig-ser85, Smed-ser85 and Smed-ser39.  
 
3.2 Introduction 
Serotonin is a biogenic monoamine and a neurotransmitter or neurohormone, found in bilateral 
animals.  In humans, Serotonin signaling is involved in diseases such as anorexia, autism and 
depression (Schloss and Williams, 1998).  In lower organisms, it mediates gut movements and 
perception of the availability of food resource and controls a range of responses and behaviors, 
including feeding, locomotion, aggression, temperature regulation, pain perception and sleep 
(Weiger, 1997).  Other factors such as Egg laying, male mating, and pharyngeal pumping are also 
regulated by serotonin in C. elegans (Carre-Pierrat et al., 2006).  
 
The fresh water triclad flat worms collectively known as “planarians” are considered the most 
primitive example of cephalization of the central nervous system (Ariens-Kappers, 1931) because 
they are thought as ancestors of bilateria and chordates (Johnson et al., 1995).  Early 
pharmacological studies proved the usefulness of planaria in the elucidation of drug action on the 
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nervous system (Carolei et al., 1975; Venturini et al., 1989).  These investigations resulted in the 
establishment of behavioral patterns due to drug action on both cholinergic and dopaminergic 
neurons (Carolei et al., 1975; Caronti et al., 1999).  Biogenic amine levels in planaria have been 
determined (Gustafsson, 1985) and the relevance of these amines; including serotonin in motor 
activity (Welsh and Williams, 1970) has been established.  Serotonin, together with dopamine in this 
phylum of organisms has been demonstrated to play an indispensable role in the regeneration of their 
body tissues (Franquinet, 1979).  
 
In mammals, serotonin mediates its effect through seven classes of serotonin receptors (5-HT1-7), 
six of which are GPCRs (Carre-Pierrat et al., 2006; Hartig, 1997).  The 5-HT1 receptor classes A, B, 
C, D and E subdivisions attenuate adenylate cyclase activity through Gi/o protein signaling while the 
5-HT5 subclass attenuates adenylate cyclase activity through Gs signaling (Amlaiky et al., 1992; 
Carre-Pierrat et al., 2006; Maroteaux et al., 1992; Plassat et al., 1992).  The 5-HT2 receptor class is 
made of 3 subclasses; 5-HT2A, 5-HT2B and 5-HT2C, all which couple to Gq/11 and increase 
phospholipase C activity (Monsma et al., 1993).  Serotonin receptor classes 4, 6 and 7 on the other 
hand, activate adenylate cyclase activity (Gerald et al. 1995; Meyerhof et al., 1993; Monsma et al., 
1993) (Table 1.4).   
 
GPCRs are one of the most important among membrane proteins because they constitute the largest 
and most diverse groups of receptor proteins (Teller et al., 2001).  With the establishment of GPCRs 
as targets of most drugs, the search for GPCR has been on the increase.  Since the inception of the 
search for GPCRs, most molecules (ligands) that signals by means of a G protein-effector system, 
has been identified with a cloned GPCR gene.  Even though a number of GPCR genes were 
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currently identified, most still exist in both higher and lower organisms of importance with no 
known ligands and are so called orphan GPCRs (oGPCRs).   
 
In lower organisms such as planaria, putative receptor identification e.g., 5-HT receptor, by means of 
degenerate primer polymerase chain reaction was demonstrated (Saitoh et al., 1996).  Planarians 
have been used in a wide range of behavioral and receptor mediated studies of certain phenotypes.  
The action of D1 or D2 dopamine selective agonists, CY 208243 and SKF 38393 were found to 
induce screw-like hyperkinesias and "C" like curling respectively in planaria, with the former inhibited 
by a D1 specific antagonist, SCH 23390 but not by a D2 antagonist, sulpiride (Venturi et al., 1989).  
While the D2 receptor antagonist, sulpiride decreases spontaneous locomotor velocity of planarians, 
amphetamines generally increase planarian motility with significant effect at 10 µM (Raffaa et al, 
2004).  At low doses, cocaine decreases planarian motility but induces a typical D2 agonist response 
at high doses (Palladini et al., 1996).  Both D1 and D2 Dopamine -selective agonists or mixed action 
agonists were also found to induce a significant increase in cAMP levels that was antagonized by 
pretreatment with specific DA blocking agent (Venturi et al., 1989).  
 
Planarian response to drug action on its nervous system has been linked to ultrastructural changes 
(Palladini et al., 1996; Margotta et al., 1997; Caronti et al., 1999).  Unlike mammals, planaria lacks 
blood brain barrier (Caronti et al., 1999), hence, the quantification of serotonin in the CNS is 
representative of serotonin levels throughout its body.  In studying planarian tolerance of addictive 
drugs, nicotine for example elicited mammalian-like effects, including decreased motility following 
acute and repeated exposure and subsequent tolerance (Rawls et al., 2011).  Planarian locomotor 
velocities were also found to decrease with increasing concentration of DMSO.  When exposed to 
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0.1-0.3% DMSO, planarians regain their motility in a time-dependent manner but with only those 
exposed to 0.1% DMSO producing consistent and full recovery of motility (Yuan et al., 2011). 
  
In the process of movement, G. tigrina, one of the several species of planarians, derives its major 
locomotory force from the cilia of its ventral epidermis.  Apart from maintaining the flat shape of 
these worms, the thick layer of the dorsal and ventral body wall muscles play a role in making 
turning movements.  While serotonin pharmacology has been widely studied in a number of species 
to be excitatory, G. tigrina displayed a unique pharmacology in response to serotonin.  Serotonin has 
a moderate inhibitory effect on cilia beating in this species of planarians.  Serotonin- mediated 
increase in cilia beating frequency on the other hand, has been reported in other species but there is 
no such documentation as receptor mediated locomotion at least in the model organism S. 
mediterranea or G. tigrina probably due to limited genomic data for the later. 
 
The activity of relevant membrane protein systems mediating GPCR activity, for example adenylate 
cyclase, has been determined in Polycelis tenuis and  enhanced two-fold by serotonin and 
synergistically enhanced 20-fold by the nucleotide analog guanosine 5′-(ß-γ-imino) triphosphate, 
Gpp(NH)p (Franquinet, 1979).  This serotonin-dependent regulation of adenylated cyclase activity is 
thought to play a physiological role in these species of organisms.  Molecules serving as mediators 
or messengers of the actions of GPCRs include cAMP, IP3, DAG and calcium.  
 
Elevated intracellular Calcium levels have inhibitory effects on the cilia of ciona intestinalis (Bergle 
and Tam, 1992) and on the gill cilia of Aecquipectin irradians (Stommel et al, 1982; Kimberley et 
al., 1996).  The reverse is true in cells such as Helisoma trivolvis (Kimberley et al., 1996).  Similarly, 
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increased cyclic AMP has been demonstrated to have cilio-excitatory effects in Ciona intestinalis 
(Bergles and Tamm, 1992), in the tracheal epithelium of rabbit (Tamaoki et al. 1989; Lansley et al. 
1992) and also in the nasal epithelium of humans (Di Benedetto et al. 1990).  Yet, in this study, the 
reverse of this was observed to be true in the planarian species, Girardia tigrina.  
 
By means of degenerate primers (for G. tigrina) and sequence specific primers (for S. mediterranea), 
we’ve cloned the gene encoding putative 5-HT4 GPCR in Girardia tigrina and cloned its homolog, 
smed-ser85, in S. mediterranea.  A second putative 5HT4 GPCR, smed-ser39, was also cloned in S. 
mediterranea based on sequence similarities to 5-HT receptors from other species.  Using RNAi, we 
performed a study of the role of these putative GPCR in serotonin-modulated movement of G. 
tigrina and S. mediterranea.  This paper is the first to explore comparatively a serotonin GPCR- 
mediated planarian motility.  It provides a direct comparison of the 5HT pharmacology and 
functional role of 5-HT receptors in the motility of the two species of planaria, G. tigrina and S. 
mediterranea. 
 
3.3 Materials and methods 
3.3.1  Girardia tigrina cultures 
G. tigrina was obtained from Ward Natural Sciences and maintained at 25 degree Celsius, in an 
aerated media.  Their diet is mainly beef liver, with which they were fed twice a week.  Worm media 






3.3.2  Gene Amplification 
The degenerate primers: 82594PC: 5HT4-1F: CCCAGCAACTGGTTGATTTT and 82595PC: 
5HT4-1R: ACTGACAAATTCCCGGTTTG; or 82596PC: 5HT4-2F: 
ACAAACACCCAGCAACTGGT and 82597PC: 5HT4-2R: GCATCTTCTTGGGCCATATT, were 
used to amplify 500 bp fragment GPCRs with the later, from previously prepared cDNA of G. 
tigrina.  Complementary att-B-sites were attached to these primer pairs (attB1 for forward, attB2 for 
reverse) to further amplify the previously amplified fragments in a second PCR cycle to attach att-b 
sites to these cloned fragments.  In a similar fashion, primers with attB1 (on forward; ASMD5939F: 
GGGG ACAAGTTTGTACAAAAAAGCAGGCT-AATGCCGGCCTGTTTCCTAT) and attB2 (on 
reverse; ASMD5939R: GGGG ACCACTTTGTACAAGAAAGCTGGGT-








and the primers with attB1 (on forward: ASMD1585F: GGGG-
ACAAGTTTGTACAAAAAAGCAGGCT-CTCCGCTTTTAATTGGAGGA) and attB2 (on reverse: 
ASMD1585R:GGGG-ACCACTTTGTACAAGAAAGCTGGGT-CTGTTTCTTTTTCCGGGGAT) 










ACCTAAAACAAATCCCCGGAAAAAGAAACAG from S. mediterranea. 
 
3.3.3  Plasmid preparation: BP-Clonase Reaction 
BP-clonase reaction was carried out as per manufacturer’s instruction (Invitorgen).  Briefly, 2µl of 
attB-PCR product of 10ng/µl and 1 µl (150ng/µl) of pDONdT7 donor vector with attP-sites were 
added to 1.5 ml eppendorf tube on ice.  Final volume was made to 8 µl with TE buffer, pH 8.0 and 
2µl of BP Clonase™ II enzyme mix was added to the reaction, mixed by brief vortexing and 
incubated at 25°C for 1 hour. 
 
3.3.4  TOP 10 Bacteria transformation 
Electrocompetent TOP 10 bacterial strains were transformed with the BP-Clonase reaction products 
(plasmid) by electroporation.  Electroporated cells were resuspended in 500µl of SOC media and 
incubated at 37 degree Celsius under shaking for 1 hour prior to plating.  Colonies were selected, 
grown in broth and plasmid preps were carried out to isolate perfect clones verified by sequencing to 





3.3.5  HT115 transformation 
Freshly plated HT115 bacteria were obtained from Lisa Timmons, Carnegie Institution of 
Washington.  Bacteria were inoculated in the presence of tetracycline, grown to stationery phase and 
stored in 80% glycerol.  A fraction of overnight cultures grown to OD595= 0.4, were resuspended in 
50mM CaCl2  and incubated on ice for 30 minutes to make calcium chloride competent HT115 cells.  
Competent cells were stored in 0.1 X CaCl2 solutions and 100µl aliquots used for the transformation 
of perfect clones from TOP10 transformation of BP-Clonase reaction products (Plasmid). 
 
3.3.6  Induction of dsRNA production 
Plasmids confirmed by sequencing as perfect clones (from TOP 10 transformation) were used to 
transform chemically competent HT115 bacterial strains and grown in LB broth overnight in the 
presence of kanamycin (vector resistance) and tetracycline (bacteria resistance).  Cells were scaled 
up in 2XYT media and grown to OD of 0.3 to 0.4.  IPTG (Isopropyl β-D-1-thiogalactopyranoside) 
were added to a final concentration of 1mM to induce dsRNA production specific to the target gene.  
Cells were incubated for a further 2 hours under shaking (250 Rev/min) after which cells were 
placed on ice to inactivate IPTG, spun down (2X) and resuspended in 2XYT and 80% glycerol for 
storage at minus 80 degree Celsius.  
 
3.3.7  RNA interference 
Worms were fed HT115 E. coli expressing dsRNA of putative 5-HT4-like GPCR or of a random 
gene cloned from an unrelated organism.  Bacteria expressing dsRNA were mixed with beef liver to 




3.3.7  Semi quantitative RT-PCR 
Semi quantitative RT-PCR was carried out to investigate the extent of knock down following RNAi. 
 
3.3.8a Membrane preparation 
Membrane preparations from worms were obtained as described by Creti et al., (1992).  Briefly, 
Planarians were washed three times in distilled water and homogenized on a previously frozen thin 
film of sucrose buffer in a motor.  The homogenate was transferred into a total volume of 20 ml of 
cold sucrose buffer (0-4 degree Celsius) made of 5x10 -3 M Tris-HCl (pH 7.4) and 0.25 M sucrose.  
Homogenates were centrifuged for 5 min at 1,500xg, the pellet discarded and the supernatant 
centrifuged for 15 min at 15,000xg.  Pellets were re-suspended in 10 ml of the sucrose buffer and 
centrifuged again at 15,000xg for 15 min.  The resulting pellet was re-suspended in cAMP buffer; 50 
mM sucrose, 50 mM glycylglycine, 10 mM creatine phosphate, 2 mM MgCl2, 0.5 mM 
isobutylmethylxanthine (IBMX), 1 mM dithiothreitol (DTT), 0.02 mM EGTA, 10 units/ml creatine 
kinase, and 0.01% bovine serum albumin suplemented with 0.1 mM ATP and 0.1 mM GTP, and 
subjected to ligand treatment.  Total suspension volume was set at 500 ul/sample, such that each 
sample would contain cell membranes from approx 3 worms.  500 ul aliquots of this membrane 
preparation correspond to individual reactions in the cAMP assay.  
 
3.3.8b cAMP assay 
Assay was carried out as described by Richards et al., (1979).  Briefly, 500l aliquots each of ligand 
or non-ligand (control) treated samples are acetylated  [12.5l (of one volume of acetic anhydride to 
two volume of triethylamine) plus the 500l cell samples in cAMP buffer].  A 100µl aliquots from 
the acetylated samples are incubated with 100µl first antibody (CV-27 Pool raised in rabbit by 
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J.Vaitukaitis, 1:30,000) and labeled I
125
; Adenosine 3',5'-cyclic phosphoric acid 2'-0-succinyl-3-[
125
I] 
iodotyrosine methyl ester, ~20,000 cpm,  in centillation viles, mixed and incubated at 4 degree 
celcius overnight.  Alongside these were cAMP standards of concentrations; 4, 8, 16, 32, 64, 128, 
256, 512 (fmol/0.1 ml) all acetylated just as the samples and with 100 l each of  first antibody and 
labelled I
125
 added as previously and incubated overnight.  A 100 l aliquot, each of NRP (Normal 
Rabbit Plasma) (1:80,000) and second antibody (goat anti-rabbit IgG, 1:40,000) were added and 
incubated at 25C for 10 min.  A 100 l aliquot of 50% normal bovine plasma were added followed 
by 1 ml of ice-cold PEG and samples centrifuged at 3000 rpm (4C) for 20 min.  The supernatant 
were aspirated and I
125 
levels of pellets of each tube counted with a gamma counter (Packard, 
B5002).  All samples were in triplicates and each member of these triplicates was in turn treated as 
triplicates. 
   
3.3.8c Motility tracking 
Basal motilities of worms were tracked in 4 ml of worm media with no drug for 15 minutes using 
Ethovision 3.1 video tracking system (Noldus).  To determine the effect of serotonin receptor 
agonists on worm motility, worms were incubated in 4mls of 10
-4 
M serotonin, 5HT [or 8-hydroxy-2, 
2-(di-n-propylamino) tetralin, 8-OH-DPAT or meta-Chlorophenylpiperazine, mCPP)] media for 30-
35 minutes prior to tracking.  For experiment to investigate second messengers mediating serotonin- 
induced moderate decrease in G. tigrina motility, worms were incubated in 2 mM CaCl2 for 5 
minute or in 10 uM forskolin for 30 minutes prior to tracking.  For experiments to investigate 
additive effects of cAMP production due to forskolin and serotonin, 10µM forskolin (Fk) and 10
-4
M 
serotonin (5-HT) were co-added to worms and motility monitored.  Recoveries from drug effect 
were monitored by tracking motility after two washout sections at 1 hour intervals.  
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3.3.9  Statistical analysis 
All data were analysed using Prizm 5.0 
 
3.4 Results 
3.4.1  Effect of serotonin on planaria motility varies between species  
To investigate the pharmacological effects of serotonin and also 8-OH-DPAT, a selective 5HT1A 
agonist (Jenck, et al., 1989) and mCPP, an agonist with preferential affinity for 5-HT1B and 5-HT1C 
receptors (Jenck, et al., 1989) and to verify the presence of serotonergic GPCRs in the flat worm and 
model organisms, S. mediterranea and G. tigrina, we monitored motility in the absence and in the 
presence of these exogenous serotonin receptor agonists.  Serotonin increased significantly the 
motility of S. mediterranea.  Contrary to its excitatory effect on S. mediterranea (figure 3.1) and 
other species as suggested in literature (Hillman & Senft, 1973; Mellin et al. 1983; Holmes and 
Fairweather, 1984; Sukhdeo et al. 1984; Maule et al. 1989; Boyle et al., 2000), serotonin has a 
minimal Cilio-inhibitory effect on G. tigrina basal motility (figure 3.1), suggesting an exception to 
the traditional observations of 5HT-induced increase in cilia beating frequency (CBF) as observed in 
a number of organisms including Helisoma trivolvis (Kimberly et al, 1996).  
 
Both the basal stimulatory and moderate inhibitory effects are reversible in the presence of the 
putative serotonin receptors mediating the effect and in the absence of the ligands; demonstrated by 
drug washout sections which restore worm motility back to basal levels (figure 3.1).  Also, while the 
serotonin receptor agonist, mCPP, has cilio-excitatory effect on S. med motility, it has no significant 
effect on G. tigrina motility suggesting at this point, reduced levels of the 5HT1B/C in this species.  
8-OH-DPAT alone however, has cilio-excitatory effect on the motility of both species. We know 
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from our previous study (Zamanian et al, 2012; under review) the extent of stimulation of cAMP 
levels by serotonin.  Since ligand washouts resulted in the restoration of basal motility, we went 
further to investigate the second messenger mediating this serotonin-induced increase or decrease in 
the motility of S. mediterranea or G. tigrina respectively. 
 
3.4.2 Serotonin-induced moderate cilio-inhibitory effect corresponds to increase 
cAMP levels in G. tigrina 
The observed moderate decrease in basal motility due to serotonin (figure 3.1) corresponds to the 
high level of the second messenger, cAMP as stimulated by serotonin in the worm membrane 
preparation (figure 3.2: 5-HT) (Data not available for Smed).  On the other hand, the observed 
increase in motility due to 8-OH-DPAT (figure 3.1) corresponds to the comparably low levels of 
cAMP as stimulated by 8-OH-DPAT in the worm membrane preparation (figure 3.2: 8-OH-DPAT).  
These together suggest an inverse relation between cAMP levels at least in G. tigrina.  In effect, 
excessive cAMP levels beyond a threshold induce an inhibitory effect on cilia action in this species 
of planaria. 
 
3.4.3 5-HT4-like receptor suppression resulted in significantly decreased cAMP 
stimulation by serotonin but not by 8-OH-DPAT 
To investigate the effect of these putative receptors on the level of cAMP production, we silenced 
the putative 5-HT receptor by feeding bacterial expressing dsRNA specific to this putative 5-HT 
receptor.  By means of semi quantitative RT-PCR, we showed the degree of knockdown of these 
putative GPCR in G. tigrina (Zamanian et al., 2012; under review) and in S. mediterranea (figure 
3.3), by RNAi.  We then subject membrane preparations from these 5-HT4-like GPCR knockout G. 
tigrina worms to exogenous serotonin stimulation, alongside those from control RNAi-fed worms 
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(figure 3.4).  While the extent of serotonin stimulation of cAMP was significantly decreased 
following knockdown of the putative 5HT4 receptor, the effect of 8-OH-DPAT in the stimulation of 
cAMP did not change significantly (figure 3.4) relative to control worms. 
 
3.4.4 5-HT4-like receptor suppression resulted in significant decrease in S. 
mediterranea motility but increase in G. tigrina motility 
To determine if the knockout putative 5-HT GPCRs have any effect on the basal motility of these 
planarian species, we tracked basal motility of the 5-HT knockout worms vs. control worms.  
Suppression of both putative 5-HT receptors (smed-ser85 and smed-ser39) in S. med (figure 3.3) 
resulted in significant decrease in worm basal motility (figure 3.5).  The suppression of putative 
smed-ser85 resulted in the most significant effect on motility.  The suppression of its homolog, Dtig-
ser85, in G. tigrina resulted in increased basal motility of worms compared to control RNAi fed 
worms (figure 3.5).  These together, suggest GPCRs even in their homologous forms in different 
species of planaria could mediate different modes of ligand action. 
 
3.4.5 Comparative effects of agonists on worm motility in the absence of putative 
GPCRs 
In G. tigrina, the absence of the putative 5HT4 GPCR has no significant effect on 8-OH-DPAT 
action on motility (figure 3.6).  This is also reflected in the insignificant change in its effect on 
cAMP levels (figure 3.4) in the presence or absence of the putative GPCR.  Even though 8-OH-
DPAT is known to be an agonist of 5HT1A, it did not attenuate adenylate cyclase activity in the 
membrane preparations.  Clearly, 8-OH-DPAT activates adenylate cyclase and causes cAMP 
accumulation in this species.  This suggests minimal levels or the absence of 5HT1A receptors at 
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least in this species of planaria.  Stimulation of 5HT5 receptors results in the attenuation of adenylate 
cyclase activity (Carre-Pierrat et al, 2006; Amlaiky et al. 1992; Maroteaux et al. 1992; Plassat et al. 
1992) just as 5HT1A.  8-OH-DPAT activation of adenylate cyclase in this species suggests the 
possible mediation of its action through putative 5HT6/7 receptors but not 5HT4 because 
suppression of the putative 5HT4 receptor seems to have no significant effect on the action of 8-OH-
DPAT as mentioned.  This suggests the presence of 5HT6/7 receptors as well in planaria.  
 
The absence of the putative 5HT4 GPCR, Dtig-ser 85 lessened the inhibitory effect of mCPP on 
cAMP (figure 3.4) but with no significant effect on motility of G. tigrina before (figure 3.1) and 
after (figure 3.6) RNAi, suggesting a minimal level of cross talk between the putative 5HT4 receptor 
and putative 5HT1B/C in this species.  Also, its effect in S. mediterranea motility remained fairly 
the same before (figure 3.1) and after (figure 3.6) RNAi of putative 5HT receptors, smed-ser85 and 
smed-ser39. 
 
3.4.6 cAMP mediates moderate serotonin-induced cilio-inhibitory effects on G. 
tigrina motility  
In order to confirm the cAMP-mediated serotonin-induced cilio-inhibition resulting in moderate 
decrease in G. tigrina motility, we added 10µM forskolin, a potent activator of adenylate cyclase 
which should accordingly, increase cAMP concentration of treated cells (Kimberley et al, 1996).  
Addition of forskolin to worms mimicked the serotonin-induced cilio-inhibition and resulted in 
moderate decrease in worm motility (figure 3.7).  Since both serotonin and forskolin stimulate 
dramatic increase in the level of intracellular cAMP (figure 3.2), we hypothesized that the additive 
effect of these two will result in tremendous levels of cAMP.  True to our hypothesis, forskolin 
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together with serotonin resulted in synergistic effect on cAMP production in membrane preparations 
(figure not shown).  Further, we expected this additive increase in cAMP production to reflect in a 
further inhibition of motility.  
 
To demonstrate this additive effect of cAMP induction by both serotonin and forskolin in intact 
worms, we co-added these two agents.  Contrary to our expectation, the effect of these agents on 
motility (figure 3.8) as a result of additive cAMP stimulation, was not significantly different from 
that induced previously by serotonin alone or by forskolin alone (figure 3.7), suggesting there is a 
limit to cAMP levels required to induce just a significant decrease in worm motility.  However, the 
mode of cAMP stimulation by forskolin in intact worm is not clear.  A similar observation was made 
by Kimberley et al, (1996), who previously observed a weak inhibitory effect of cAMP in the 
regulation of cilia beating frequency (CBF) in early embryos of Helisoma trivolvis.  
 
3.4.7  Calcium mediates an increase in G. tigrina motility 
In order to verify the moderate inhibitory role of cAMP on the motility of G. tigrina, we explored 
the effect of calcium as the second potential second messenger on motility by means of membrane 
depolarization using CaCl2.  Calcium stimulation resulted in a dramatic increase in worm motility 
(figure 3.7).  This first confirms that serotonin stimulation of the putative serotonin GPCRs in these 
worms does not result in Ca
2+
 release as a second messenger or the putative serotonin GPCRs are not 
Gq-coupled.  Further, the co-addition of calcium and serotonin, resulted in a significant inhibition of 
the calcium-induced increase in motility (figure 3.7), again suggesting the moderate inhibitory effect 





G. tigrina, formerly, Dugesia tigrina is well known for its remarkable regenerative capabilities.  
Upon division, its anterior portion acts normally while the posterior becomes limited in movement 
prior to complete regeneration of a new head and cilia.  For these reasons, it has been one of the 
most used planarian species in pharmacological studies and the teaching of biology of regeneration 
and movement.  However, due to limited genomic data of this turbellaria, little is known about 
receptor mediated mechanisms underlying their movement.  
 
With the advent of genomic data gradually becoming available for some of these planarians 
including S. mediterranea, the study of GPCR-mediated pharmacological events in planarians is on 
the increase.  The reason being that, these flatworms shared receptor homologs with some parasites 
as well as humans (Gentile et al., 2011).  Targets studied in these can be harnessed into parasite 
studies to hamper parasite movement.  In our previous studies (Zamanian et al., 2012; under review), 
we’ve demonstrated that exogenous serotonin stimulates increased cAMP levels in planaria to very 
significant magnitudes.  Here in this study, we’ve investigated the effect of this magnitude of cAMP 
due to serotonin in the presence or absence of a putative 5-HT4 receptor in G. tigrina; and the effect 
of suppression of homologs of these putative receptors on the motility of S. mediterranea.  
 
The moderate decrease in motility of G. tigrina observed in the presence of serotonin corresponds to 
increased cAMP levels due to serotonin.  Previous studies by Kimberley et al., (1996), suspected an 
inhibitory role of cAMP on the movement of Helisoma trivolvis, a pond water snail.  We have 
confirmed this observation by treatments of G. tigrina with agent known to be indicative of cAMP 
dependent response e.g. adenylate cyclase activator (Price and Goldberg, 1993), which decreased 
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worm motility just as serotonin.  This is a unique observation in this planarian species considering 
the fact that the reverse of this is true in cilio-excitation of; the lateral gill cilia of Mytilus edulis 
(Akira, 1987) and the palatine mucosal cilia in frog (Maruyama et al. 1984) such that increase 
cytoplasmic cAMP levels are thought to mediate these processes.  
 
Further, by means of RNAi, we silenced the putative GPCR, D.tig-ser85, resulting in a significant 
decrease in the level of cAMP when stimulated by exogenous serotonin.  Interestingly, the absence 
of this receptor, hence, significantly decreased cAMP levels due to serotonin, resulted in moderate 
increases in the basal motility of these worms or no significant decrease in the basal motility of these 
worms due to serotonin.  This suggests that basal cAMP in these worms serves as a check on the rate 
of movement or acts as a regulator of basal motility of G. tigrina.  A confirmation of RNAi 
specificity is evidenced in the observation that upon knockdown of D.tig-ser85, 8-OH-DPAT action 
on the level of cAMP stimulation and on motility remained approximately the same while that of 
serotonin on the level of cAMP stimulation changed significantly and moderately on worm motility.  
 
3.5.1  5HT4 receptor pharmacology in G. tigrina 
Pharmacologically, 5HT1A receptors have high selective affinity for 8-hydroxy-2, 2-(di-n-
propylamino) tetralin (8-OH-DPAT) and results in the inhibition of forskolin-stimulated adenylate 
cyclase activity (Misane and Ogren, 2000; Leone et al., 2001); our putative receptor demonstrated 
otherwise; 8-OH-DPAT activated adenylate cyclase.  mCPP binds preferentially to 5HT1B/C and 
inhibits adenylate cyclase activity as observed in figure 3.4, suggesting the presence of 5HT1B/C 
receptors in G. tigrina.  While mCPP is also an agonist of 5-HT2A-2C receptors resulting in 
activation of phospholipase C-β (Leone et al., 2001) with subsequent increase in calcium levels, the 
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stimulation of D.tig-ser85 demonstrated otherwise; serotonin or mCPP stimulation did not result in 
calcium release; rather, exogenous calcium was used to induce increase G. tigrina motility.  5HT3 




 conducting ligand gated ion channels and differ from all other 
5HT receptors (Fink et al., 2007; Leone et al., 2001).  Our target sequence analysis shows no 
homology to characterized 5HT3 receptors.   
 
Even though they were first characterized in the CNS, pepripheral 5HT4 receptors are widely spread 
in higher animals; heart, vasculature, urinary tract and alimentary tract neurons where they facilitate 
cholinergic transmission and mucosal electrolyte secretion (Hegde and Eglen, 1996).  They are Gs- 
coupled, hence elevate adenylate cyclase activity or increase cAMP levels (Ford and Clarke, 1993).  
The same effect has been observed upon cDNA transfection and stimulation of both long and short 
isoforms of the 5-HT4 receptor in cells (Gerald et al., 1995).  
 
The most definitive classification of receptors is dependent on amino acid sequence, transductional 
or second messenger coupling and criteria of signaling, pharmacology (Hegde and Eglen, R., 1996).  
While all the 5-HT receptor subtypes mentioned above have been initially identified by 
pharmacological approaches and subsequently cloned (Peroutka, 1990), the remaining 5HT5, 5HT6 
and 5HT7 were directly characterized by molecular cloning (Boess and Martin, 1994; Branchek and 
Zgombick, 1997).  The use of heterologous expression of recombinant receptors in cell lines has 
been reported to have unusual drug-receptor interaction behaviors depending on receptor densities 
transfected or G protein types in a given cells (Kenakin, 1997).  An alternative loss-of-function 
approach validated in our previous studies (Zamanian et al., 2012; under review) now proves 




Based on each of the definitive steps of receptor classification, we have characterized two 
homologous serotonin GPCRs in planaria that mediates different serotonin-induced effects on 
motility.  In G. tigrina, Dtig-ser85 mediates serotonin-induced moderate decrease in motility while 
its homolog in S. mediterranea mediates significant increase in motility.  We have verified the 
second messenger coupling of this GPCR in G. tigrina to be cAMP (as highlighted in table 3.1) and 
consequently suggest cAMP mediates moderate serotonin-induced decrease in G. tigrina motility.  
There are three possibilities in literature that explains our finding of serotonin-induced moderate 
decrease in G. tigrina motility.  
 
First, the stimulation of 5-HT4 receptor comprising cholinergic neuron additionally inserted between 
the serotoninergic and GABAergic neurons modulates GABA release (Fink et al., 2007).  Their 
stimulation results in the increased release of acetylcholine (Ishtiyaque and Ramakrishna, 2011) 
which, in turn, modulates the release of GABA in bidirectional manner, an example of a more 
complex regulatory neuronal circuit of serotonin (Fink et al., 2007).  Both acetylcholine and GABA 
were reported to be inhibitory neurotransmitters in planarians (Buttarelli et al., 2008).  At high 
potency activation of 5-HT4 receptors, increased release of GABA is mediated by M1 and/or M3 
while the inhibition of GABA release is mediated by M2 receptors at low potency activation of 
5HT4 receptors (Fink et al., 2007). 
 
Second, in mammals, 5-HT4 receptor-mediated relaxation of certain gastrointestinal and vascular 
tissues is attributed to cAMP-induced reduction in intracellular Ca
2+
 levels (Hegde and Eglen, 1996).  
We have demonstrated in our study that serotonin stimulation of 5HT4 did not result in the elevation 
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of intracellular calcium; that motility increases only in the presence of exogenous calcium; that the 
increased levels of cAMP induced by serotonin stimulation of Dtig-ser85 resulted in intracellular 
calcium inhibition, hence decrease motility.  
 
Third, the inhibitory response of 5HT4 receptor stimulation in gastrointestinal tract is also believed 
to be as a result of direct smooth muscle relaxation (Hegde and Eglen, 1996).  We’ve made such 
similar observation by monitoring turn angle effects in response to serotonin and the two other 
agonists, where serotonin seem to have negligible contractile effect on muscle cells in this species 
(data not shown).  5HT4 receptor stimulation results in both excitatory and inhibitory effects 
(Reeves et al., 1991; Baxter et al., 1991) and the rank order of potency of 5HT4 agonist and 
antagonists also indicated the inhibitory effects of 5HT on 5HT4 receptors (Hegde and Eglen, 1996).  
These together or alternatively, possibly play significant roles in our observation of serotonin-
induced moderate decrease in G. tigrina motility.   
 
3.5.2  5HT4 receptor pharmacology in S. mediterranea 
In a similar fashion, we have characterized two serotonin GPCRs, smed-ser85 and smed-ser39 in 
Schmidtea mediterranea.  Both receptors mediate increased motility in response to serotonin and 
serotonin receptor agonists, 8-OH-DPAT and mCPP.  Suppression of these two putative GPCRs 
resulted in significant decrease in worm motility.  In mammals, cAMP activation of protein kinase A 
in myenteric neurons potentially result in closure of potassium channels, with consequent cell 
excitability and the release of neurotransmitters (Eglen et al., 1995).  5-HT4 receptors in the 
hippocampus are also largely documented to modulate locomotor activity e.g. in rats (Takahashi et 




Even though we were unable to determine the second messenger couplings of these homologs in this 
species of planaria, coupled with the fact that serotonergic systems in these lower organism might 
differ to some degree in behavior compared to that in higher organisms, our pharmacological 
findings agree with previous observations.  In terms of transductional coupling, these together or 
alternatively possibly explain our observation of increase motility in response to serotonin.  At this 
point we conclude based on two of the definitive criteria for GPCR classification; the homology and 
the 5HT pharmacology of our receptor coupled with physiological consequence of its absence due to 
RNA interference, in the organism; that these two receptors play a significant role in locomotory 
behavior of S. mediterranea. 
 
3.6  Conclusion 
By means of RNAi, we have characterized two novel 5-HT4 GPCRs in the flat worms, G. tigrina 
and S. mediterranea.  We’ve shown that, these putative 5-HT4 GPCRs mediates serotonin-induced 
cilio-excitation in S. mediterranea (smed-ser85, smed-ser39) and serotonin-induced moderate cilio-
inhibition in G. tigrina (Dtig.ser-85).  We demonstrated that the serotonin-induced moderate 
decrease in motility is mediated by cAMP and not calcium.  We’ve also shown that in the absence of 
this receptor, cAMP levels due to serotonin significantly decrease; that this decrease in cAMP 
lessens the inhibition of G. tigrina basal motility.  Within the context of receptor homology, 
transductional coupling, 5HT pharmacology coupled with an alternative loss-of-function approach, 
we conclude these putative GPCRs compares with characterized 5HT4 receptors, hence, could be 
classified as planarian 5HT4 GPCRs, namely Dtig-ser85, Smed-ser85 and Smed-ser39.  Future work 
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aims at investigating the homolog of these receptors in S. mansoni, a human parasite largely studied 
in our lab. 
 
3.6.1  Summary 
1. Effect of serotonin on planaria motility varies between species. 
2. Serotonin-induced moderate cilio-inhibitory effect corresponds to increase cAMP levels in G. 
tigrina. 
3. Putative 5-HT4 (Dtig-ser85) knockout results in decrease cAMP stimulation by serotonin but not 
by 8-OH-DPAT. 
4. Putative 5-HT4 (Dtig-ser85) knockouts results in significant decrease in S. mediterranea motility 
but moderate increase in G. tigrina motility. 
5. There are comparative effects of agonists on worm motility in the absence of putative GPCRs. 
6. cAMP mediates serotonin-induced moderate cilio-inhibitory effects on G. tigrina motility.  
7. Calcium mediates an increase in G. tigrina motility. 
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Figure 3.1  Serotonin stimulates homologous receptors in different planarian species differently 
Addition of serotonin to S. mediterranea resulted in significant increased in worm motility but 
induced a moderate decrease in G. tigrina motility.  In a similar fashion, the serotonin receptor 
agonist, mCPP, produced a significant increase in S. mediterranea motility but had no significant 
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effect on G tigrina motility.  8-OH-DPAT produced similar effect in these species.  These drug 
effects were reversible in the presence of the receptor and in the absence of agonist (Demonstrated 
by washout sections).  Each bar represents the mean (plus S.E.M.) motility of 18 worms and 








M] and 8-OH-DPAT [10
-4
M] stimulate significantly [cAMP] levels compared to 
basal levels (P<0.0001) while mCPP [10
-4
M] significantly inhibits basal cAMP levels.  Each bar 
represents the mean (plus S.E.M.) of [cAMP] from 9 samples (due to 3 samples, each triplicated) 






Figure 3.3  Semi quantitative RT-PCR of putative 5HT4 GPCR in S. mediterranea 
Worms were fed 4 times with bacteria expressing dsRNA specific to cloned putative 5-HT4-Like 
receptors: A. Lane 1: 100bp ladder, Lane 2-4: worms with 5HT39 receptor knocked down.  Lane 5-
8: Control worms fed with bacteria expressing a random gene.  B. Lane 1: 100bp ladder, Lane 2-4: 
worms with 5HT4 (85)-Like receptor knocked down.  Lane 5-8: Control worms fed with bacteria 
expressing a random gene.  C. (Refer C. at figure A.6; Zamanian et al., 2012; under review). 
 
                                






Figure 3.4  Effects of 5HT and 5HT-R agonists on basal intracellular cAMP of planaria subjected to 
RNAi 
Control RNAi: worms fed with bacteria expressing dsRNA of random gene (Control RNAi.Basal vs. 
Control RNAi.5HT, Control RNAi.8-OH-DPAT, and Control RNAi.mCPP) 5HT4-L RNAi: worms 
fed with bacteria expressing dsRNA of putative 5-HT4 Receptor (5HT-4 RNAi.Basal vs. 5HT-4 
RNAi.5HT, 5HT-4 RNAi.8-OH-DPAT, 5HT-4 RNAi.mCPP).  5HT-4 silenced worms shows a 
dramatic decrease in intracellular cAMP levels (P<0.0001) stimulated by serotonin [10-
4
 M] 
compared to levels stimulated in control RNAi treated worms.  8-OH-DPAT on the other hand, 
shows no significant change in the extent of cAMP level stimulation after putative 5-HT knockdown 
(absence of receptor) compared to levels stimulated in controls (in the presence of receptor) 
suggesting an alternative receptor available for 8-OH-DPAT [10-
4
 M] action (5HT6/7).  The 
inhibitory effects of mCPP [10-
4
 M] on cAMP were lessened in the absence of the putative receptor 



































































































Each bar represents the mean (plus S.E.M.) of [cAMP] from 9 samples (due to 3 samples, each 


















            



























Figure 3.5  Effect of silenced putative serotonin receptors on planaria motility 
Putative 5HT-4 GPCRs: smed Ser85 and smed Ser39 silenced in S. mediterranea by RNAi, resulted 
in significant decrease in motility (P<0.0001).  Putative 5HT4 GPCR: Dt-ser85 silenced in G. tigrina 
by RNAi, resulted in increased basal motility.  Each bar represents the mean (plus S.E.M.) motility 













































































                   
 
 
Figure 3.6  The absence of putative serotonin receptors affects the action of serotonin on worm 
motility 
In S. mediterranea: silenced putative serotonin GPCRs: smed-ser85 and smed-ser39 resulted in 
moderate decrease in the magnitude of both serotonin and 8-OH-DPAT stimulation of motility but 
enhanced that of mCPP.  In D. tigrina: silenced putative serotonin GPCR, D.tig-ser85 resulted in 
moderate increase on the magnitude of serotonin inhibitory action on the worm motility but no 
significant change in the effects of 8-OH-DPAT or mCPP.  Each bar represents the mean (plus 













































































































































































































































































Figure 3.7  Effect of increasing Intracellular calcium on worm motility 
Addition of 2 mM CaCl2 resulted in a dramatic increase in worm motility (P<0.0001).  Addition of 
10µM forskolin (P<0.0001) mimicked 100 µM serotonin-induced moderate decrease in motility.  







Figure 3.8  Effect of increasing Intracellular cAMP on worm motility 
The co-addition of serotonin [10
-4
M] and Fk [10µM], resulted in a decrease in G. tigrina motility to 
a magnitude not significantly different from that due to 5-HT alone.  Each bar represents the mean 












































Table 3.1  Characterization of 5HT4 in Planaria 
 
Known agonists and G protein couplings of mammalian serotonin GPCRs even though might have 
different pharmacological profiles, serve as leads at this point in the streamlining of the functional 
role of a putative serotonin receptor among an array of characterized ones in planarians.  In 
mammals, DPAT stimulation of 5HT1A results in adenylyl cyclase inhibition (Gi coupling) but 
resulted in the activation of adenylyl cyclase in G. tigrina.  It eliminates (N) the possibility of 
5HT1A stimulation in G. tigrina by DPAT.  MCPP stimulation of 5HT1B/C in mammals result in 
the inhibition of adenylyl cyclase and the same is observed in G. tigrina.  It accepts (Y) the 
possibility of 5HT1B/C stimulation in G. tigrina by MCPP.  By definitive characterization, MCPP 
increased cAMP levels following RNAi but failed to have physiological bearing on the motility of 
the worm.  It is concluded as crosstalk.  MCPP stimulation of 5HT2 (A-C) in mammals results in 
intracellular calcium increase (Gq-coupled) but the reverse is true in G. tigrina, hence, eliminates (N) 
the possibility of preferential 5HT2 (A-C) stimulation in G. tigrina by MCPP.  Serotonin stimulation 
did not result in increased intracellular calcium, hence, eliminates the possibility of 5HT3 
stimulation.  Exogenous CaCl2 however, increased worm motility.  The elimination criterion of 
5HT3 at this point is also the fact that our putative serotonin receptor bears no homology to 
characterized mammalian 5HT3 receptors.  Serotonin stimulation of mammalian 5HT5 results in the 
inhibition of adenylyl cyclase but the reverse is true in G. tigrina, eliminating the possible 
availability and stimulation of 5HT5 in this species.  Serotonin stimulation of mammalian 5HT4, 6 
and 7 results in the stimulation of adenylyl cyclase as observed in G. tigrina.  However, based on 
sequence homology, coupled with characteristic worm response, our putative 5HT-R, Dtig-ser85 





CHAPTER  4 CONCLUSION 
 
This dissertation enumerates the step-by-step identification and characterization of a unique biogenic 
amine GPCR, as well as a catecholamine-responsive GPCR in the protozoan Tetrahymena 
thermophila.  We demonstrated the biological relevance of the Tetrahymena receptor (TetEPI-1) as 
related to bacterial engulfment.  Further, in the presence of serotonin, TetEPI-1 was shown to have 
been stabilized in inactive state, giving the course to suspect serotonin as its potential inverse agonist 
or antagonist.  TetEPI-1 is a potential therapeutic target for selective manipulation of related 
pathogenic protozoa, especially considering the inverse agonism is the paradigm for antihistamine 
drugs that stabilize H1 receptors in the absence of histamine during chronic allergic responses of 
atopy. 
 
Second, by means of alternative loss-of-function technique, this dissertation described the successful 
characterization of two novel serotonergic GPCR mediating locomotory events in two species of 
flatworms, Girardia tigrina (Dtig.ser-85) and Schmidtea mediterranea (smed-ser85, smed-ser39).  
Serotonin, by virtue of its dual effects, depending on its targets, demonstrated both cilio-excitatory 
and moderate cilio-inhibitory effect in these organisms.  In the process of characterizing these 
receptors, this work established flatworm species differences in their response to serotonin.  The 
suppression of these GPCRs demonstrated significant impairment in the motility of S. mediterranea 
while a decrease in cAMP also lessens the moderate inhibitory effects of serotonin on G. tigrina 
locomotion, a clear indication of the relevance of these receptors to these worms.  These putative 
GPCRs compare with characterized 5HT4 receptors, hence, could be classified as planarian 5HT4 




It is worth mentioning that motile effects cannot be totally abolished because a myriad of 
serotonergic GPCRs possibly exist in these organisms and a specific suppression of one could have 
negligible effects.  A look at the dynamics of second messenger levels (before and after RNAi) and 
worm locomotion, is tempting to generalize an inverse relation between levels of cAMP and the 
motility of G. tigrina such that increased cAMP levels are inhibitory to worm motility and vice 
versa.  
 
In effect, this dissertation, by means of an alternative loss-of-function technique (RNAi) and the 
availability of known ligands for a range of receptors, coupled with transductional coupling 
determination, has established that the physiological function of a given receptor among a population 
of receptors can be streamlined.  Following the targeting of a given receptor, the determination of G 
protein transduction coupling is an additional check on the validation of the intact actions of the non-
targeted receptors based on response to known ligands and second messenger levels following their 
stimulation.  The effect of these ligands on the phenotypes is yet an additional observation that 
confirms if the elimination of a target receptor resulting in a cross talk between existing receptors 
has any physiological bearing on the phenotype of the organism.  Based on these observations, 
future studies first aimed at finding other adrenergic agents capable of agonizing or antagonizing 
TetEPI-1 and second, investigating the homolog of these characterized serotonergic GPCRs in the 
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  Abstract 
GPCRs represent the largest known superfamily of membrane proteins extending throughout the 
Metazoa.  There exists ample motivation to elucidate the functional properties of GPCRs given their 
role in signal transduction and their prominence as drug targets.  In many organisms, these efforts 
are hampered by the unreliable nature of heterologous receptor expression platforms.  We validate 
and describe an alternative loss-of-function approach for ascertaining the ligand and G protein 
coupling properties of GPCRs in their native cell membrane environment.  Our efforts are focused 
on the phylum Platyhelminthes, given the heavy health burden exacted by pathogenic flatworms, as 
well as the role of free-living flatworms as model organisms for the study of developmental biology.  
RNA interference (RNAi) was used in conjunction with a biochemical endpoint assay to monitor 
cAMP modulation in response to the translational suppression of individual receptors.  As proof of 
principle, this approach was used to confirm the neuropeptide GYIRFamide as the cognate ligand for 
the planarian neuropeptide receptor GtNPR-1, while revealing its endogenous coupling to Gαi/o.  The 
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method was then extended to deorphanize a novel Gs-coupled planarian serotonin receptor, DtSER.  
A bioinformatics protocol guided the selection of receptor candidates mediating 5-HT-evoked 
responses.  These results provide functional data on a neurotransmitter central to flatworm biology, 
while establishing the great potential of an RNAi-based deorphanization protocol.  Future work can 
help optimize and adapt this protocol to high throughput platforms as well as other phyla. 
 
  Introduction 
GPCRs have been the subject of intense research scrutiny due to their central role in eukaryotic 
signal transduction and their exploitability as drug targets (Flower, 1999; Wise et al., 2002; 
Lagerstrom and Schioth, 2008).  Once identified, GPCRs undergo deorphanization, the process of 
pairing orphan receptors with their cognate ligands.  Current approaches to GPCR deorphanization 
have severe limitations and are inefficient for large-scale projects.  The predominant approaches all 
require the transient or stable heterologous expression of GPCRs in a surrogate cell system and in 
most cases, this expression occurs in cells derived from other species and phyla (Tate and 
Grisshammer, 1996; Mertens et al., 2004; Chung et al., 2008).  This has introduced a significant 
bottleneck in the way of both the pharmacological and structural characterization of GPCRs (Tate 
and Grisshammer, 1996; McCusker et al., 2007). 
 
The complex regulatory processes that guide the correct folding and export of receptors to the cell 
membrane (Sexton et al., 2001; Duvernay et al., 2005; Dong et al., 2007; Kobilka, 2007) are not 
necessarily well-conserved across cell lineages.  In the event that a GPCR is successfully expressed 
on the surface of a host cell, the receptor must operate in conjunction with a foreign complement of 
accessory and signaling proteins.  Further, the structural and functional integrity of receptors can be 
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altered by local membrane composition (Opekarová and Tanner, 2003; Pucadyil and Chattopadhyay, 
2006).  The exact post-translational requirements for proper receptor expression and function can 
vary greatly among receptors, making the task of identifying a suitable heterologous system a 
receptor-specific process of trial-and-error (Tate and Grisshammer, 1996).  Although heterologous 
expression is not a theoretically challenging feat, individual targets routinely prove to be recalcitrant 
and consume inordinate effort.  In view of these concerns, a simple receptor deorphanization method 
that could be applied in a native cell or membrane environment could side-step some of these 
concerns. 
 
  Flatworm GPCRs 
The phylum Platyhelminthes houses prominent human pathogens as well as tractable model 
organisms.  Flatworm GPCRs represent lucrative anthelmintic targets, as evidenced by the biological 
activities of their putative ligands (McVEIGH et al, 2005; Ribeiro et al., 2005) and the crucial 
biological functions of these receptors in other organisms (Wilkie, 2000; Keating et al., 2003).  
Signaling pathways associated with the GPCR superfamily have been identified as potential targets 
for life-cycle interruption of flatworm parasites (Fitzpatrick et al., 2009; Taft et al., 2010). The recent 
availability of platyhelminth genomic data (Berriman et al., 2009; Zhou et al., 2009; Robb et al., 
2008) has led to the accumulation of a wealth of receptor and ligand data.  A comprehensive in silico 
protocol revealed over 117 Schistosoma mansoni and 460 Schmidtea mediterranea GPCRs, which 
were classified using phylogenetic, homology-based, and machine-learning approaches (Zamanian et 
al., 2011).  Bioinformatics and proteomics-based studies have similarly led to the expansion of the 




The pharmacological characterization of orphan flatworm receptors is likely to generate valuable 
drug discovery leads, while enhancing our understanding of basic receptor biology in this important 
phylum.  Reliance on heterologous expression platforms has hampered efforts to implement 
functional assays to identify receptor agonists.  Only a handful of flatworm GPCRs have thus far 
been deorphanized, with receptors expressed in such divergent cellular environments as CHO 
(Omar, 2007), HEK293 (Hamdan, 2002; Taman, 2009), COS7 (Hamdan, 2002), yeast (Taman, 
2009; El-Shehabi, 2010), and Xenopus oocyte cells (Nishimura, 2009).  We describe a relatively 
simple loss-of-function deorphanization approach that could be applied in a native cell or membrane 
environment.  This alternative strategy could help catalyze a first-pass mapping of receptors and 
ligands in this and other phyla. 
 
  Inversing the paradigm: RNAi as a deorphanization tool 
We validate an RNA interference (RNAi)-based method that allows receptors to undergo 
deorphanization without the need for full-length cloning and transport to a heterologous expression 
system. In principle, a collection of putative ligands are screened against membrane preparations to 
evaluate their effects on second-messengers downstream of GPCR activation.  RNAi is then used to 
assay whether observed responses can be altered or abolished by the knockdown of individual 
receptors from the membrane preparations.  A successful “hit” confirms expression of a given 
receptor, functionally pairs the receptor with a given ligand, and couples the receptor with a specific 
G protein signaling pathway.  Bioinformatics approaches can be used to help identify receptors as 
putative targets for a particular ligand, or conversely, to narrow the list of potential ligands for a 




The primary biochemical endpoints of GPCR activation are typically assayed by recording agonist-
evoked changes in cAMP (Gαs and Gαi/o) or Ca2+ (Gαq) levels.  A variety of established labeling and 
detection schemes (e.g. fluorescent, luminescent, and radioisotope) are available for these second 
messengers (Thomsen et al., 2005).  In this study, we focus our efforts on the Gαs and Gαi/o 
pathways and employ a radioimmunoassay (RIA) for cAMP detection.  Monitoring adenylyl cyclase 
modulation of cAMP allows us to examine two of the three major GPCR activation endpoints.   
 
While this loss-of-function approach limits pharmacological analysis, it is likely adaptable to high 
throughput platforms and can serve as an efficient ligand-receptor mapping tool for certain receptor 
classes.  It should be noted that ligands and receptors can display pharmacological promiscuity.  
Ligands can act through more than one receptor and receptors can respond to more than one ligand, 
with a range of affinities.  Further, receptors responsive to a given ligand do not necessarily share the 
same G protein coupling profile and are likely to be expressed in different abundances.  However, 
this approach only concerns itself with the contribution of individual receptors to differences 
between control and RNAi response profiles.  The scale and directionality of these differences 
provide information relevant to ligand responsivity and G protein coupling, respectively.  The basic 








  Materials and methods 
  Planarian maintenance 
Dugesia tigrina (Ward’s Natural Science, Rochester, NY) colonies were maintained in the 
laboratory in aerated spring water on a regular feeding cycle (3 times per week). Planaria were 
randomly selected and isolated in approximately 50-worm groupings for RNAi feeding cycles and 
cAMP assays. 
 
  RNA interference 
Primer3 (Untergasser et al., 2007) was used to select primers to selectively amplify 400-600 bp 
fragments of GtNPR-1 and 5HT receptor candidate DtSER.  BLAT (Kent et al., 2002) was used to 
help guard against potential off t-target effects of suppression triggers using the very nearly-related 
S. mediterranea genome.  A 465 bp fragment of GtNPR-1 was amplified from a full length clone of 
Gt-NPR1 housed in pcDNA3.1 (+), with the primers 5’- TGGATCTTTCCAGCGACTCT-3’ 
(forward) and 5’-ATGGTTCGTTCGACGTTTTC-3’ (reverse).  A 586 bp fragment of DtSER was 
amplified from D. tigrina cDNA isolated using RNAqueous (Ambion) and RETRoscript (Ambion), 
with a degenerate forward primer: 5’-GGKATGGAAGTATTTCTGGGRAT-3’ (forward) and 5’-
TGGCATCTTCTTG GGCCATATTTCT-3’ (reverse).  An RNAi control sequence was amplified 
from Aedis aegypti cDNA with primers 5’-AATGCCGGCCTGTTTCCTAT-3’ (forward) and 5’- 
AGCATCCTTTTTCTTGTGCG-3’ (reverse), corresponding to a putative odorant receptor 
(VectorBase id: AAEL013422 (Lawson et al., 2007).  Second-round PCR was performed for each 
target sequence using the original gene-specific primers flanked by Gateway Cloning system 
(Invitrogen) recombination sites: 5’-GGGGattB1- 3’ (forward) and 5’-GGGG-attB2-3’ (reverse).  
Entry sequences were subcloned into the pPR244 (pDONRdT7) (Reddien, 2005) destination vector 
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with corresponding attP1 and attP2 recombination sites using BP Clonase II (Invitrogen).  Clones 
were transformed into TOP10 Electrocompetent E. coli (Invitrogen) and sequence confirmed.  RNAi 
vectors were introduced to HT115 (DE3) cells for transcription of dsRNA, followed by bacterial-
mediated feeding per standard protocol. 
 
  Semi-quantitative RT-PCR 
Total RNA was extracted from individual D. tigrina with RNAqueous (Ambion), followed by 
removal of DNA contaminants with TURBO DNase (Ambion).  First strand cDNA synthesis was 
carried out with the RETROscript kit (Ambion), as part of a two-stage RT-PCR.  PCR optimization 
was carried out with the Quantum RNA 18S Internal Standards kit (Ambion) per manufacturer 
instructions.  18S ribosomal RNA was used as an endogenous standard for normalizing measures of 
gene expression and reducing sample-to-sample variation.  cDNA samples were used in parallel as 
templates for multiplex PCR with gene-specific and 18S rRNA primer pairs.  PCR reaction products 
were visualized on 1.2% electrophoretic gel with the Kodak Gel Logic 112 imaging system, and 
amplicon intensities were analyzed with standard software to derive relative transcript abundances. 
 
  Membrane preparation 
Planaria were washed twice with cold cAMP buffer containing 50 mM sucrose, 50 mM 
glycylglycine, 10 mM creatine phosphate, 2 mM MgCl2, 0.5 mM isobutylmethylxanthine (IBMX), 1 
mM dithiothreitol (DTT), 0.02 mM EGTA, 10 units/ml creatine kinase, and 0.01% bovine serum 
albumin. Worms were kept on ice for 5 min and then homogenized on ice for 2 min with a Teflon 
homogenizer.  This preparation was centrifuged at 5,000 X g for 5 min, with the pellet that included 
cell debris discarded.  This centrifugation step was then repeated.  The supernatant was centrifuged 
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at 40,000 X g for 30 min at 4
o
C.  The supernatant was discarded, and the membrane-containing 
pellet was resuspended via sonication in cAMP buffer suplemented with 0.1 mM ATP and 0.1 mM 
GTP.  Total suspension volume was set at 500 ul/sample, such that each sample would contain cell 
membranes from 3 worms.  500 ul aliquots of this membrane preparation correspond to individual 
reactions in the cAMP assay.  Samples were incubated with various concentrations (and 
combinations) of forskolin and/or putative ligands (peptide or biogenic amine) at 37
o
C for 20 min to 
stimulate cAMP production.  Forskolin and peptide ligands were dissolved in DMSO, with final 
reaction mixtures containing <0.1% DMSO.  DMSO has no measurable effect on cAMP in this 
range (data not shown).  Samples were centrifuged at 3,000 X g for 5 minutes after ligand 
incubation, and 400 ul of supernatant from each sample (3 samples per treatment) was transferred 
into a fresh tube for cAMP determination using radioimmunoassay. 
 
  cAMP determination 
cAMP levels were measured with RIA as previously described (Richards et al., 1979) with minor 
modifications.  100 µl aliquots from each sample or known standard (standard curve range: 4 - 512 
fmol cAMP) were acetylated and incubated overnight at 4
o
C with primary cAMP antibody 
(1:30,000) and cAMP [
125
I] (approx 20,000 cpm).  100 µl of NRP (1:80,000) and secondary antibody 
(goat anti-rabbit IgG; 1:40,000) were added, followed by incubation at 25
o
C for 10 min. 100 µl of 50 
% normal bovine plasma and 1 ml of ice-cold PEG were added to the scintillation vials.  Samples 
were centrifuged at 3,000 rpm (4
o
C) for 20 min.  The supernatants were aspirated and 
125
I levels in 
the pellets were assayed via gamma counter (Packard, B5002).  For a given experiment, each sample 




  Bioinformatics 
HMMER-2.3.2 (Eddy et al., 1998) was used to build a profile HMM for invertebrate 5-HT receptors.  
Training sequences were procured from GPCRDB and aligned with Muscle 3.6 (Edgar et al., 2004).  
The profile HMM was constructed with hmmbuild and calibrated with hmmcalibrate.  This model 
was used to search a curated dataset of putative S. mediterranea receptors with hmmpfam.  The 
resulting matches were ranked by E-value and the top 20 full-length hits were further examined.  
Putative hits were matched with their nearest-related S. mansoni and D. japonica homologs, and also 
searched against the NCBI nr database with BLASTp.  Maximum parsimony phylogenetic analysis 
was carried out with the Phylip 3.6 (Retief et al., 2000) package. 
 
  Statistical analysis 
In cases where a ligand had an overall inhibitory effect on Fk-stimulated cAMP, basal cAMP levels 
were set as a baseline for individual RIA experiments and cAMP values were normalized with 
respect to the level of Fk-stimulated cAMP (set at 100%).  In cases where a ligand had an overall 
stimulatory effect on cAMP, cAMP values were normalized with respect to basal cAMP (set at 
100%).  This allowed us to join datasets from repeated experiments with differing basal cAMP levels 
due to variance in the quality and yield of individual membrane preparations.  One-way analysis of 
variance (ANOVA) was used with Tukey’s post hoc test for multiple comparison analysis of cAMP 
levels associated with different treatments, for both normalized and raw values.  Significances are 






  Results and discussion 
  cAMP assay optimization and ligand screen 
A cell membrane preparation protocol was adapted (Humphries et al., 2004) and optimized for 
planaria, and used to generate samples for treatment with putative GPCR ligands.  The downstream 
effects of ligand incubation on cAMP levels were monitored using a cAMP RIA.  A screen was first 
carried out on Dugesia (Girardia) tigrina membrane preparations with a small number of peptides 
and biogenic amines.  These ligand classes are prominent in platyhelminth biology (Mcveigh et al., 
2005; Ribeiro et al., 2005; McVeigh et al., 2009; Collins et al., 2010), and there is a strong 
likelihood that a subset signal through one or more receptors coupled to either the Gαs or Gαi/o 
pathways.  This would presumably be made apparent by stimulation of basal cAMP levels or 
inhibition of forskolin (Fk)-stimulated cAMP levels (Insel et al., 2003) as measured by RIA, 
respectively.   
 
Included in this initial screen were the only two ligands definitively coupled to planarian GPCRs: the 
neuropeptide GYIRFamide and the biogenic amine serotonin (5-HT; 5-hydroxytryptamine).  It was a 
reasonable assumption that both GYIRFamide and 5-HT would modulate cAMP levels in a whole 
organism membrane preparation.  The D. tigrina receptor GtNPR-1 was previously deorphanized, 
showing a potent dose-dependent response to the neuropeptide GYIRFamide in mammalian cell 
culture (Omar et al., 2007).  Chimeric G proteins (Gαqi5 and Gαqo5) were used to divert downstream 





More recently, a Dugesia japonica 5-HT GPCR has been deorphanized using Xenopus laevis 
oocytes (Nishimura et al., 2009) and there is long-established evidence of 5-HT stimulation of 
cAMP in both S. mansoni (Kasschau et al., 1982; Estey et al., 1987) and other planarian species 
(Cret`I et al., 1992), suggesting that 5-HT acts through one or more Gs-coupled GPCRs.  
 
Alongside GYIRFamide and 5-HT, we included neuropeptide F (NPF) and octopamine as putative 
ligands.  NPF has been shown to inhibit Fk-stimulated cAMP production in membranes isolated 
from S. mansoni (Humphries et al, 2004).  Given the identification of planarian NPF homologues 
(McVeigh et al., 2009; Collins et al., 2010), we hypothesized that this peptide would have a similar 
inhibitory effect on cAMP levels.  The results of this primary screen show that 10−5M 5-HT 
drastically stimulates cAMP production, while 10−4M GYIRFamide, 10−4M NPF, and 10−4M 
octopamine inhibit Fk-stimulated cAMP accumulation in Dugesia membrane preparations (figure 
A.2) to varying degrees.  These changes in [cAMP] can be viewed as the additive response profile of 
each ligand. 
 
We chose to first pursue the response profiles of GYIRFamide, provided that GtNPR-1 is a known 
target of GYIRFamide in D. tigrina.  As proof of principle, we investigated whether or not this 
would be apparent using this loss-of-function assay.  Given that the inhibition of adenylate cyclase 
by GYIRFamide is less potent than that brought on by NPF; this also serves as a more difficult trial 






  Coupling cAMP assay with RNAi: GtNPR-1 proof of principle 
  Establishing RNAi-mediated receptor suppression  
Double-stranded (ds) RNA was introduced to isolated D. tigrina colonies using a bacterial-mediated 
feeding protocol.  Planaria were randomly selected, isolated into treatment groups, and fed either 
non-flatworm control dsRNA or GtNPR-1 dsRNA.  A two-week RNAi feeding cycle consisted of 
four evenly spaced feedings, followed by a four-day starvation period.  Semi-quantitative RT-PCR 
was used to confirm gene knockdown.  A small number of planarians were randomly selected from 
both experimental and control groups to assay GtNPR-1 suppression, and the remaining planarians 
were used for membrane assays.  Significant GtNPR-1 knockdown (> 80%) is consistent and 
apparent in the experimental group, while GtNPR-1 expression remains robust in the control group 
(figure A.3) relative to endogenous standard. 
 
  Deorphanization via omparison of response profiles  
Membranes were prepared from both control and GtNPR-1 dsRNA-fed planarians, and treated with 
Fk (10−4M), GYIRFamide (10−4M), and Fk (10−4M) + GYIRFamide (10−4M).  RIA was used to 
assay cAMP levels corresponding to these treatments.  Comparison of the response profiles reveals 
near-complete abolishment of GYIRFamide-evoked inhibition of Fk-stimulated cAMP in the 
GtNPR-1 knockdown group (figure A.4, Table A.1).  Overall, GYIRFamide reduces Fk-stimulated 
cAMP production by an average of approximately 30% in the control group, and this inhibition was 
completely abolished by the suppression of GtNPR-1 expression in the RNAi group.  These results 
confirm that GtNPR-1 is agonized by GYIRFamide and further establish that this receptor is natively 




  In silico target selection 
The two ligands that most drastically stimulated and inhibited adenlyate cyclase activity in our 
primary ligand screen were 5-HT and NPF, respectively.  We decided to focus on 5-HT in an 
attempt to deorphanize a Gαs-coupled receptor.  To identify and rank 5-HT receptor candidates, a 
profile HMM was built with sequences procured from GPCRDB (Horn et al., 2003).  Training was 
focused on 62 full-length invertebrate 5-HT and 5-HT-like receptors.  This model was used to search 
against S. mediterranea GPCR sequence datasets (Zamanian et al., 2011) and the results were ranked 
by E-value.  The top 20 receptor candidates were used as BLASTp (Altschul et al., 1990) queries 
against the NBCI “nr” database.  This was used to identify receptors displaying 5-HT receptor 
homology, and to filter against receptors that displayed a non-specific range of biogenic amine 
receptor-related homology.  
 
Receptors that survived this filter were compared to their nearest-related S. mansoni and D. japonica 
homologs (Table A.2).  While the bioinformatics evidence suggests multiple receptor targets for 5-
HT, we narrowed our list to the best-conserved receptors between parasitic and free-living flatworms 
and used degenerate PCR to amplify a putative 5-HT receptor from D. tigrina.  The selection 
strategy is outlined in Table A.2.  The amplified receptor is labeled DtSER and maximum parsimony 
phylogenetic analysis places this receptor among a group of putative free-living and parasitic 







  RNAi-based deorphanization of planarian 5-HT receptor 
DtSER transcript expression was confirmed via PCR, and knockdown was elicited following the 
protocol described for GtNPR-1.  Similar levels of transcript knockdown were obtained (figure A.6).  
Membranes from control and DtSER dsRNA-fed worms were isolated and treated with 5-HT 
(10−4M).  The response profiles reveal a significant decrease (> 30%) in 5-HT evoked cAMP 
stimulation in the DtSER RNAi preparations compared to the control preparations.  Just as with the 
neuropeptide receptor knockdown experiments, basal cAMP levels did not differ between control 
and experimental groups (figure A.7, Table A.3).  These results represent the successful 
deorphanization of DtSER in its native membrane environment.  DtSER responds to 5-HT and is 
coupled to the Gαs pathway.  Serotonin receptors are implicated in motility and regeneration due to 
the phenotypic effects of serotonin in this phylum (Farrell et al., 2008; Saitoh and Yuruzume, 1996).  
Given that this receptor mediates significant increases in cAMP levels in response to serotonin, it is 
likely involved in these or other important physiological processes. 
 
  Conclusions 
This study shows the utility of combining RNAi with biochemical endpoint assays to as a means of 
deorphanizing GPCRs in their native membrane environment.  The approach was first validated 
using the only deorphanized flatworm neuropeptide GPCR (GtNPR-1), confirming agonism by 
GYIRFamide while providing information about its endogenous G protein coupling profile.  The 
orphan D. tigrina GPCR DtSER was shown to respond to 5-HT, revealing its endogenous G protein 
pathway and illustrating the utlity of applying an in silico strategy to candidate receptor selection.  
While these loss-of-function strategy side-steps some of the concerns and difficulties associated with 
heterologous GPCR expression, there is significant room for improving both the sensitivity and 
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scalability of this assay.  The heavy tissue requirements of the membrane preparation protocols 
employed introduce a potential rate-limiting step.  Further optimizations of membrane or whole cell 
preparation protocols in this phylum could allow for more efficient and robust pharmacological 
analysis.  This assay could conceivably be adapted to higher-throughput platforms, and extended to 
include GPCRs that signal through the Gαq pathway.  Conveniently, establishing receptor-specific 
RNAi in planaria allows for the accumulation of loss-of-function phenotypic data in parallel to 
pharmacological data.  In this regard, the study of planarians can inform flatworm parasite biology.  
Biasing the receptor and ligand pool to those best conserved between parasitic and free-living 
flatworms could shed light on new targets for chemotherapeutic intervention. 
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    Figures 
 
 Apply Ligand (L) to membrane or cell preparation to generate control profile. 
 I. If B > A, L acts through one or more Gαs-coupled receptors. 
II. If D < C, L acts through one or more Gαi-coupled receptors. 
 Apply in silico protocol to predict L-responsive GPCR (R). 
 Suppress expression of R with RNAi to generate comparative profile. 
 Normalize cAMP data. 
 I. For stimulatory L: x* = x/A¯ and x* = x/A¯' 
  L: x* = (x − A¯)/C¯ and x* = (x − A¯')/C¯' 
 Analyze cAMP data. 
 I. If B'* < B*, R is L-responsive and Gαs coupled. 
Alternatively, If B'* > B*, R is L-responsive and Gαi coupled. 
 II. If D'* > D*, R is L-responsive and Gαi coupled. 
 Alternatively, If D'* < D*, R is L-responsive and Gαs coupled. 
 
Figure A.1  Logic of RNAi-based deorphanization experiment. 
The general set of experimental outcomes for an RNAi-based deorphanization experiment focused 
on the Gαs and Gαi pathway are shown.  Letters A − D and A0 − D0 each represent cAMP datasets 
for particular treatment conditions.  Potential results are described with respect to the notion that a 
given ligand may act on multiple GPCRs that are not necessarily coupled to the same G protein (Gαs 
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or Gαi).  Abbreviations: NT, no treatment; Fk, forskolin; L, ligand; R, receptor; RNAi-control, 
control membrane preparation; RNAi-R, R-suppressed membrane preparation; x, cAMP 





Figure A.2  Peptide and biogenic amine ligand cAMP screen performed against isolated D. tigrina 
membranes 
RIA cAMP outputs are shown as mean ± SEM, and asterisks represent statistically significant 
differences compared with either control or treatment with Fk alone; * P < 0.05, *** P < 0.001, one-
way ANOVA, Tukey post hoc test.  Red bars are compared with Fk treatment: octopamine (OCT), 
GYRIFamide (GYIRF), and neuropeptide F (NPF) all inhibit Fk-stimulated cAMP at 100 uM.  The 
green bar is compared with the control condition: serotonin (5-HT) stimulates basal cAMP.  These 
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changes in cAMP are likely GPCR-mediated, and should therefore be altered in a ligand-specific 




Figure A.3  Semi-quantitative PCR reveals GtNPR-1 knockdown 
Lane 1 is a 100 bp DNA ladder; lanes 2-5 represent individual GtNPR-1 dsRNA-fed planarians, and 
lanes 6-9 represent control dsRNA-fed planarians.  The bottom band (~300 bp) is the 18S internal 
standard, and the top band (~400 bp) shows GtNPR-1 expression.  The top band disappears in the 
experimental group, confirming near abolishment of receptor expression in these worms.  Relative 
band intensities (GtNPR-1/18S rRNA) for GtNPR-1 RNAi group: 0.44 ± 0.15.  Relative band 
intensities for control group (band location manually selected): 0.08 ± 0.02.  This corresponds to > 






Figure A.4  RNAi-based GtNPR-1 deorphanization 
Treatment groups are Control (control dsRNA) and GtNPR-1 RNAi (GtNPR-1 dsRNA). Treatments 
are C (control), Fk (10−4 M forskolin), and Fk + GYIRF (10−4 M forskolin and 10−4 M 
GYIRFamide).  Each bar is the mean (± SEM) of 3 individual experiments.  Basal cAMP levels 
were set as a baseline for each individual experiment, and cAMP values were normalized with 
respect to the level of Fk-stimulated cAMP (set at 100%).  This allowed us to join datasets with 
differing basal cAMP levels, due to variance in the quality and yield of individual membrane 
preparations.  Analysis of the raw cAMP values of individual experiments renders the same results 
(Table 1).  Asterisks indicate significance at P < 0.001 (***), and “ns” indicates no significant 





Figure A.5  Maximum parsimony tree of serotonin receptors 
Phylogenetic analysis was performed using planarian (S. mediterranea and D. japonica), parasite (S. 
mansoni), human and C. elegans 5-HT receptors and putative 5-HT receptors.  TM domains I-VII 
were extracted from the alignment for bootstrapping (bootstrap value = 1000).  Outlined receptors 
are significantly diverged from vertebrate and ecdysozoan serotonin receptors.  DtSER (red) was 







Figure A.6  Semi-quantitative PCR reveals DtSER knockdown 
Lane 1 is a 100 bp DNA ladder; lanes 2-5 represent individual DtSER dsRNA-fed planarians, and 
lanes 6-9 represent control dsRNA-fed planarians.  The bottom band (~300 bp) is the 18S internal 
standard and the top band (~480 bp) shows DtSER expression.  The top band disappears in the 
experimental group, confirming near abolishment of DtSER receptor expression in these worms. 
 
 
Figure A.7  RNAi-based DtSER deorphanization 
 
Treatment groups are Control (control dsRNA) and DtSER RNAi (DtSER dsRNA).  Treatments are 
C (control) and 5-HT (10−4 M).  Each bar is the mean (± SEM) of 3 individual experiments.  cAMP 
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levels were normalized to basal cAMP levels (set at 100%), and the datasets were joined.  DtSER 
knockdown corresponds to significantly decreased cAMP stimulation (~32%) in response to 5-HT.  
Analysis of the raw cAMP values of individual experiments renders the same results (Table 3).  
Asterisks indicate significance at P < 0.001 (***), and “ns” indicates no significant difference (one-
way ANOVA, Tukey post hoc test). 
 
  Tables 
Table A.1  RNAi-based GtNPR deorphanization cAMP raw values 
 
RIA-determined cAMP values (pM) are provided for three separate experiments (mean ± SEM).  
Treatments: C (control), Fk (Forskolin), Fk + G (Forskolin + GYIRFamide).  The amount of isolated 
membrane differs between experiments, as evidenced by basal cAMP levels.  This is in part due to 
differences in the size, number, and feeding behavior of worm batches used for membrane isolation.  
Analysis (one-way ANOVA, Tukey) of these raw datasets establishes abolishment of cAMP 
inhibition brought on by GYIRFamide associated with GtNPR-1 suppression.  For each 
experimental grouping, Fk is compared to Fk + G.  Asterisks indicate significance at P < 0.001 








Table A.2  5-HT receptor candidate selection 
 
5-HT profile HMM hits are ranked by E-value for S. mediterranea.  Additional sequences were 
appended via homology searches.  This putative list of planarian 5-HT receptors was searched 
against the NCBI nr database using BLASTp.  Receptors that exclusively showed serotonin-related 
homology in their top returned hits are marked with ‘+’.  HMMTOP (Tusnady et al., 2001) was used 
to predict the number of TM domains for each sequence.  Putative 5-HT receptors from S. mansoni 
(Zamanian et al., 2011) and D. japonica (Saitoh et al., 1997) were searched against the filtered 
HMM pool.  The two nearest-related homologs for each of four S. mansoni receptors are shown, 
along with E-value and overlap length for each pairing.  Similarly, the top pairings for each of three 
D. japonica receptors are shown.  Three sequence clusters (bold) show high sequence conservation 
between parasite and planarian sequences.  DjSER-7 has been previously deorphanized (Nishimura 
et al., 2009) and we therefore excluded this cluster from further consideration.  Among the two 
remaining options, our choice of the sequence cluster highlighted in red is justified as follows: 1) the 
planarian sequences in this grouping share the highest level of sequence identity with their parasite 
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sequelog, 2) the presence of two closely-related planarian sequences improves the likelihood of 
success for degenerate PCR as a strategy to amplify the D. tigrina homolog, and 3) deorphanization 
of a receptor in this cluster will assign a pharmacological identity to a novel subset of GPCRs. 
 
Table A.3  RNAi-based DtSER deorphanization cAMP raw values 
 
RIA-determined cAMP values (pM) are provided for three separate experiments (mean ± SEM).  
Treatments: C (control) and 5-HT (serotonin).  Analysis (one-way ANOVA, Tukey) of these raw 
datasets establishes a significant decrease in 5-HT mediated cAMP stimulation associated with 
DjSER suppression.  For each experiment, Control groups and 5-HT treated groups are compared 
between Control RNAi and DjSER RNAi conditions.  Asterisks indicate significance at P < 0.001 













APPENDIX B Deorphanization of a bacterial lipopolysaccharide-
recognizing G protein-coupled receptor in Entamoeba histolytica  
 
A paper to be submitted 
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  Abstract 
Entamoeba histolytica is the causative agent of amebic dysentery, a worldwide protozoal disease that 
results in approximately 100,000 deaths annually.  The virulence of E. histolytica may be due to 
interactions with host bacterial flora whereby trophozoites engulf colonic bacteria as a nutrient 
source.  The engulfment process depends on trophozoite recognition of bacterial epitopes that 
activate phagocytosis pathways.  EhGPCR-1 was previously recognized as a putative GPCR used by 
Entamoeba histolytica during engulfment of bacteria.  In the present study, we attempted to 
deorphanize EhGPCR-1 using a heterologous GPCR yeast system.  We determined that bacterial 
lipopolysaccharide (LPS) serves as an agonist for EhGPCR-1 and that LPS stimulates EhGPCR-1 in 
a concentration-dependent manner.  Additionally, we demonstrated that Entamoeba histolytica 
prefers to engulf bacteria with intact LPS.  Thus EhGPCR-1 is an LPS-recognizing GPCR that is a 
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  Introduction 
Entamoeba histolytica is the causative agent of amebic dysentery, a worldwide protozoal disease that 
results in approximately 100,000 deaths annually (WHO, 1997).  Infection with E. histolytica often 
manifests as colitis but trophozoites can also gain access to the systemic circulation resulting in liver 
or brain abscesses (Fotedar et al., 2007; Petri and Singh, 1999).  The majority of infections are 
asymptomatic (Huston, 2004) and many of the host factors determining the outcome of infection 
have not been well characterized.   
 
The virulence of E. histolytica may be due to interactions with host bacterial flora.  Co-culture with 
bacteria can restore amoebic virulence in Entamoeba cell lines attenuated through serial passage 
(Bos and Van de Grind, 1977; Wittner and Rosenbaum, 1970) and this effect is related to an up-
regulation of genes associated with enhanced phagocytosis (Debnath et al., 2007).  Specifically, E. 
histolytica exhibits enhanced adherence and cytotoxic abilities following engulfment of 
enteropathogenic bacteria (Galvan-Moroyoqui, 2008; Hirata, 2007)  Furthermore, phagocytic ability 
is essential for the pathogenesis of amebiasis and strongly correlated with virulence especially 
considering that E. dispar, a non-pathogenic species, is not able to engulf cells (Hirata, 2007; 
Rodriguez, 1986).  
 
E. histolytica is also dependent on colonic bacteria as a nutrient source for trophozoites.  Prior to the 
advent of selective medium, trophozoites could only be grown in culture medium containing bacteria 
(Diamond, 1978).  Although trophozoites are now routinely grown in bacteria-free culture medium, 




Phagocytosis is a stepwise process that is initiated by activation of receptors that bind an 
extracellular target and proceed to activate cytoskeletal rearrangements.  While many studies have 
established the importance of bacterial engulfment by E. histolytica, the specific protozoan cell 
surface receptors that recognize bacteria have not been identified. 
 
In metazoan phagocytes, GPCRs have been found to initiate phagocytosis of bacteria (Soumita et al., 
2011).  Picazarri et al. (2005) described EhGPCR-1, a putative GPCR associated with vesicular 
trafficking of proteins that localize to phagocytic cups (Picazarri et al., 2005).  EhGPCR-1 is highly 
expressed in pathogenic E. histolytica but not in E. dispar (unpublished observations) possibly 
accounting for the differential engulfment of bacteria by these species (Pimenta et al., 2002).  The 
ligand for EhGPCR-1 had not been identified prior to the present study.   
 
We hypothesized that since EhGPCR-1 has a putative role in the initiation of phagocytosis, it may 
recognize bacterial prey that is an essential nutrient source and potentiators of virulence for E. 
histolytica.  In the present study, we used a heterologous yeast expression system to screen bacterial 
components for their ability to activate EhGPCR-1.  In addition, we tested the ability of E. 
histolytica trophozoites to selectively predate bacteria based on the presence of a bacterial 







  Materials and methods 
  Creation of the yeast expression vector encoding EhGPCR-1   
DNA encoding EhGPCR-1 (accession number AY880672) was synthesized by GeneScript using 
codon optimization for yeast expression. The gene was cloned into the pUC57 vector and the cDNA 
was amplified with forward and reverse primers adding the restriction sites NcoI and BamHI 
(5’GCCATACCATGGATCAATCATTCGGTAATCAA3’)  
and (5’GCCATAGGATCCTTAAGTCAAGTTAATTTCTCTTGAA3’) to the 5’ and 3’ ends of the 
amplicon, respectively.  Purified amplicons and the linearized yeast expression vector Cp4258, 
which bears a leucine auxotrophic marker (Kimber et al., 2009; Wang et al., 2006), were co-digested 
with NcoI and BamHI restriction endonucleases.  The EhGCR-1 gene was then ligated into Cp4258 
using T4 DNA ligase (New England Biolabs).  The resulting plasmid was transformed into E. coli 
and individual clones were selected and aerobically grown overnight at 37oC in Luria-Bertani (LB) 
broth containing 32g/mL ampicillin.  Plasmid DNA was purified using HiSpeed Plasmid Mini Kit 
(Qiagen) and inserts were sequenced to confirm cDNA orientation and fidelity. 
 
  Transformation of yeast with the EhGPCR-1 expression vector    
Saccharomyces cerevisiae strain CY 18043 (J. Broach, Princeton University, USA) was used as the 
yeast recipient since this strain is a histidine auxotroph that exhibits histidine prototrophism upon 
GPCR activation even for exogenous receptors (Kimber et al., 2009; Wang et al., 2006).  Non-
transformed CY 18043 yeast were grown in YPD media supplemented with all essential amino 
acids.  Cells at mid-log phase (OD600 equals 0.3 to 0.5) were transformed with 1g cDNA construct 
or 1 g empty vector (mock transformants) in the presence of 200g salmon sperm DNA 
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(Invitrogen) and lithium acetate (100mM, Sigma-Aldrich).  Transformed cells were incubated at 
30oC and then heat shocked at 42oC for 15 minutes.  Cells were placed on leucine-deficient media 
[1x YNB (Difco), 1x yeast synthetic dropout medium supplement without leucine (Sigma), 10 mM 
ammonium sulfate (Sigma), and 50% glucose] to select for transformation of Cp4258 with the 
EhGPCR-1-encoding plasmid.  Transformants were verified by isolating plasmids (Promega) and 
colonies expressing the EhGPCR-1 were verified by PCR prior to the functional assay. 
 
  Yeast growth assay  
Leucine-deficient media was inoculated with yeast expressing EhGPCR-1 or mock transfected yeast 
that were grown at 30oC to an OD600 equal to one.  Cells were washed three times with 
leucine/histidine deficient medium [1x YNB (Difco), 1x yeast synthetic drop out medium 
supplement lacking leucine and histidine (Sigma), 10 mM ammonium sulfate (Sigma), 50% glucose, 
50 mM 4-morpholinepropanesulfonic acid, pH 6.8] and resuspended in 1mL leucine/histidine-
deficient media, to a density of 15–20 cells/µL.  Approximately 3,000 cells were added to each well 
of 96-well plates containing the same medium along with test agonists in a total volume of 200L.  
Cells were grown at 30oC for approximately 24 hours.  Initial and final OD600 values were 
measured with a spectrophotometer to determine growth of the yeast. 
 
  Agonist and antibody binding studies   
E. coli (K12 strain, Sigma) and rough strain E. coli MG1655 (K12 derivative, N. Cornick, Iowa State 
University, USA) were grown aerobically overnight in LB broth at 37oC.  To produce bacterial 
lysates, cultures were incubated for 10 minutes at 100oC.  Purified lipopolysaccharide (LPS) from E. 
coli 0111:B4 (Sigma) was also used as a test agonist. 
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Serial dilutions of whole bacteria, lysate, or LPS were added to leucine/histidine-deficient media for 
use in the yeast growth assay.  Antibody-mediated inhibition of GPCR activation was performed by 
co-incubating test agonists in 200L media with 25L equine anti-LPS antibodies (MG Biologics, 
Ames, IA; 1:10 titer), in the absence or presence of proteinase K (Qiagen, 50g/mL, 3 hrs., 37oC).  
   
  Bacterial engulfment assay   
Bacteria were labeled by growing 8 x10
8
 CFUs in 1 mL of LB broth containing 10μg FITC.  Cells 
were washed three times with and resuspended in M199 medium (Gibco) supplemented with 25mM 
HEPES and 5.7mM cysteine (M199s). E. histolytica HM1 trophozoites were grown under anaerobic 
conditions at 37ºC in TYI Medium (Diamond et al., 1978).  Trophozoites were harvested by 
centrifuging for 5 min at 1,000 RPM and 2.5x10
5
 trophozoites were added to each well of a 24-well 
tissue culture dish in 500µL of TYI medium.  Cells were allowed to adhere to the wells for 1 hr at 
37ºC under anaerobic conditions.  Each well was washed twice with pre-warmed M199s medium 
and inoculated with 8.75x10
6
 bacteria in a final volume of 500µL of M199s medium.  Bacteria and 
amoebae were co-incubated at 37ºC for 25 min.  The medium was aspirated and 500µL ice-cold 110 
mM D-galactose was added to each well to detach trophozoites.  Cells were pelleted centrifuging for 
5 min at 1,000rpm and washed with 500µL ice-cold 110 mM D-galactose. Cells were then fixed in 
4% paraformaldehyde for 20 min at 37ºC.  Paraformaldehyde was neutralized with 50mM 
ammonium chloride, and cells pelleted and resuspended in phosphate-buffered saline.  5µl aliquots 
were fixed with Fluoromount-G mounting medium (Southern Biotech; Birmingham, AL) on a 
microscope slide.  These specimens were examined by fluorescence microscopy on an Olympus 
BX51 microscope with a UPlan F1 40x/0.75 objective equipped with an HBO lamp and dichroic 




For flow cytometry experiments, at least 10,000 amoebic cells were analyzed for the presence of 
internalized bacteria on a Becton Dickinson FACScalibur (excitation 488nm) and fluorescence 
measured in the FL1 channel.  Data was acquired using CellQuest Software (BD Biosciences) and 
analyzed by Flow Cytometry Analysis software (Tree Star, Inc.; Ashland, OR). 
 
  Results 
  EhGPCR-1 activation by bacterial lysate 
To determine if EhGPCR-1 recognizes bacterial components, we monitored the response of the 
receptor to bacterial lysates using a histidine auxotrophic yeast functional expression assay (Kimber 
et al., 2009; Wang et al., 2006).  The GPCR of interest is expressed in histidine auxotrophic yeast 
that will grow in histidine-deficient medium when the receptor is stimulated by its cognate ligand or 
agonist.  Thus, in histidine-deficient media, receptor activation induces yeast growth that is 
quantitated spectrophotometrically.  Receptor activation was calculated as increased yeast growth 
compared to growth of mock-transfected yeast exposed to the same ligand or agonist.  
 
Addition of E. coli K12 lysates to EhGPCR-1-expressing cells resulted in a significant increase in 
yeast growth (Figure B.1).  This effect was markedly attenuated by the addition of anti-LPS 
antibodies and the effect of the anti-LPS antibodies was abrogated by proteinase K.  Addition of a 
rough strain of E. coli K12, which lacks the outer O-antigen of LPS (Johns et al., 1983), stimulated 
EhGPCR-1 to a lesser extent.  No effect was noted when the EhGPCR-1 expressing yeast were 




  Concentration-dependent activation of EhGPCR-1 by LPS   
Since EhGPCR-1 was putatively activated by LPS, we examined the ability of LPS to stimulate 
EhGPCR-1 in a concentration-dependent manner.  EhGPCR-1-expressing yeast were incubated with 
various concentrations of purified LPS isolated from E. coli 0111:B4 and histidine prototrophism 
was measured in the yeast.  As shown in Fig. 2, LPS activated EhGPCR-1 in a concentration-
dependent manner with an EC50 of 15 nM (figure B.2).   
 
  Preferential predation of E. coli expressing LPS by Entamoeba histolytica trophozoites   
To determine if E. histolytica trophozoites selectively predate bacteria based on the presence of LPS, 
we compared the engulfment of E. coli K12 and a rough strain of E. coli.  Bacteria were 
fluorescently labeled with FITC and co-incubated with E. histolytica HM1 trophozoites.  
Trophozoites were washed to remove bacteria that were not engulfed or attached and the number of 
E. histolytica trophozoites containing bacteria was quantitated by flow cytometry.  Phagocytosis 
assays revealed that 23.2% of trophozoites contained E. coli K12 while only 3.8% of trophozoites 
engulfed the rough strain.  This represents an 80% reduction in the bacterial engulfment capability of 
E. histolytica (Fig B.3). 
  
  Discussion 
Previous work indicates that EhGPCR-1 is linked to phagocytic pathways in E. histolytica (Picazarri, 
2005).  The goal of the present study was to deorphanize EhGPCR-1 by determining its cognate 
ligand and to conduct engulfment assays demonstrating the functional activity of the ligand. GPCRs 
are cell surface receptors that sense the extracellular environment and are activated by a variety of 
ligands such as catecholamines, peptides, lipids, carbohydrates, etc. While GPCRs have been well 
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studied in vertebrates, the study of their role in protozoan physiology is only in its infancy.  GPCRs 
are excellent drug targets, reflected by the fact that 30-50% of currently marketed drugs target these 
receptors (Flower, 1999; Wise et al., 2002).  EhGPCR-1 is the first GPCR to be characterized in E. 
histolytica and it may represent an important chemotherapeutic target in this pathogen.     
 
The present study utilized a novel yeast auxotroph assay for screening GPCRs against potential 
ligands.  This approach has recently been applied to GPCRs from parasitic helminths (Kimber et al., 
2009; Wang et al., 2006), and may represent a valuable tool for the study of protozoan receptors 
since culture of these organisms is often difficult.  Utilizing this approach, we demonstrated that 
EhGPCR-1 is activated by a bacterial component of E. coli, an effect that was sensitive to anti-LPS 
antibodies.  Purified LPS induced concentration-dependent EhGPCR-1 activation although this 
response was not as robust as the response to bacterial lysates.  Structural variances between LPS 
from E. coli K12 and E. coli 0111:B4 might explain differences in receptor activation.  
Alternatively, additional bacterial components may be required to maximal occupancy of EhGPCR-
1.  Further research is needed to unveil the unique pharmacology aspects of EhGPCR-1 in E. 
histolytica, e.g. agonist affinity, binding co-operativity, and receptors expressed on each cell. 
 
Based on the results of our yeast expression assay, we hypothesized that E. histolytica initiates 
bacterial engulfment after recognizing bacterial LPS.  Phagocytosis assays demonstrated an 80% 
reduction in the number of trophozoites containing bacteria when the bacterial prey lacked O-
antigen, the outermost layer of the LPS.  This result is supported by previous research indicating that 
E. histolytica primarily engulfs Gram-negative pathogens (Mirelman et al., 1983). Other 
investigators have also demonstrated selective predation of bacteria by amoebae based upon 
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bacterial O-antigen (Wildshutte et al., 2007; Wildshutt et al., 2004).  While E. histolytica appears to bear 
a receptor that binds bacterial LPS, it is unclear if other taxa of protozoa possess similar mechanisms 
for initiation of bacterial engulfment. 
 
In summary, this study demonstrates the utility of a heterologous yeast expression system in the 
deorphanization of EhGPCR-1, a GPCR used in phagocytosis by pathogenic E. histolytica.  
EhGPCR-1 is activated by bacterial LPS, suggesting that this receptor may be used to initiate 
phagocytosis upon the recognition of bacterial prey.  Functional studies supported the role of LPS in 
engulfment of E. coli by E. histolytica.  Protozoan GPCRs may represent innovative drug targets and 
their role in regulating protozoan physiology merits further investigation.   
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Figure B.1  E. coli K12 lysate stimulation of histidine prototrophism in histidine auxotrophic yeast 
expressing EhGPCR-1 
Yeast growth was measured in histidine-deficient media in the presence of E. coli K12 lysates.  
Growth was also determines in the presence of these lysates plus intact anti-LPS antibodies or anti-
LPS antibodies digested with proteinase K.  EGPCR-1 activation was also determines in the 
presence of a rough strain of E. coli K12.  Receptor activation is expressed as a percent growth over 
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mock-transfected yeast.  Data are expressed as mean + SEM.  For bar with bacteria only, n=6; for 
antibody experiments n=3   
 
 
Figure B.2  Concentration dependent activation of EhGPCR-1 by LPS 
Activation of EhGPCR-1 by bacterial LPS is concentration dependent with an EC50 of 15nM, based 
on an estimated molecular wright of 2000gm/mole for LPS.  The open triangle represents the 
response of mock-transfected yeast to the highest concentration of LPS used.  Each data point 







Figure B.3  E. histolytica preferential engulfment of E. coli expressing LPS 
E. coli were labeled with FITC and incubated with E. histolytical trophozoites.  Percent of 
trophozoites harboring bacteria was determined using flow cytometry.  Each bar represents the mean 
+ SEM of percent of trophozoites that contained bacteria after 25 min, of co-incubation (n=3, 10,000 








APPENDIX C RNAi protocols 
Freezing bacterial stocks: (Source: http://www.ciwemb.edu/, 03/31/2012) 
Request a freshly plated HT115 bacterial cell from Lisa Timmons, Carnegie Institution of 
Washington.  Inoculate fresh single colony of bacteria into 2.5 ml LB+ antibiotic(s).  Grow to early 
stationary phase.  Pipette 0.25 ml 80% glycerol (sterile) and 0.75 ml culture into a sterile screw-cap 
freezer tube.  Mix. Quick freeze on dry ice/ethanol and store at -80C.  
Quick procedure for making competent bacterial cells using CaCl2 
(http://paramecium.cgm.cnrs-gif.fr/RNAi/BactRNAi_Timmons.html, 03/31/2012) 
1. Inoculate overnight culture in LB + antibiotic (TET for HT115 (DE3) strain + antibiotic 
appropriate for any plasmids in cells) (2-5ml).  Shake overnight at 37C.  
2. Inoculate 25 ml LB + antibiotic with overnight culture, 1:100 dilution. Grow cells to 
OD595= 0.4.  Can grow cells in 50 ml sterile centrifuge tube.  
3. Spin cells 10 min 3000 rpm at 4C.  
4. Resuspend pellet in 0.5X original volume cold, sterile 50 mM CaCl2 (12.5ml). 
Resuspend by GENTLY pipetting up and down a few times with a wide bore pipet--no 
vortexing.  
5. Incubate on ice 30 min.  
6. Spin as before at 4C.  
7. Resuspend pellet as before in 0.1X original volume CaCl2 (2.5ml). Keep cells cold (4C).  





BP Clonase reaction 
Creating a Gateway® entry clone  
(Adupted/ modified from invitrogen BP Clonase Reaction Manual) 
1. Add the following components to a 1.5 ml tube at room temperature and mix: 
attB-PCR product (=10 ng/µl; final amount ~15-150 ng) 1-7 µl 
Donor vector (150 ng/µl) 1 µl 
TE buffer, pH 8.0 to 8 µl 
2. Thaw on ice the BP Clonase™ II enzyme mix for about 2 minutes. Vortex the BP 
Clonase™ II enzyme mix briefly twice (2 seconds each time). 
3. To each sample (Step 1, above), add 2 µl of BP Clonase™ II enzyme mix to the reaction 
and mix well by vortexing briefly twice. Microcentrifuge briefly. 
4. Return BP Clonase™ II enzyme mix to -20°C or -80°C storage. 
5. Incubate reactions at 25°C for 1 hour. 
6. Add 1 µl of the Proteinase K solution to each sample to terminate the reaction. Vortex 
briefly. Incubate samples at 37°C for 10 minutes. 
 
Transformation 
Transform 6 µl of each LR reaction into 60 µl of One Shot ® Top ten Electrocompetent Cells 
(Catalog no. C8540-03) by first mixing gently both the Bp Clonase reaction and the Top Ten 
cells on ice followed by electroporation (0.2 cm electrode gap, 10 µF, 5 milliseconds).  Add 
400 µl of S.O.C. Medium and incubate at 37°C for 1 hour with shaking.  Plate 20 µl, 50 µl 
and 100 µl of each transformation onto kanamycin, 100 µg/ml (100 µl / 200 ml agar) 
selective plates (or the appropriate selection marker for your donor vector).  Note: Any 
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competent cells with a transformation efficiency of >1.0 × 10 8 transformants/µg may be 
used. 
 Plasmid Preparation 
 Promega protocol 
 PCR Check 
 Using gene specific primers with no attB sites 
Perfect clone transformation pcr check: 
                                   
 
Sequence confirmation of perfect clone 
    Send 20 µl of prep for sequencing at DNA facility, ISU or other 
 
Transformation of chemically competent (CaCl2 Competent) HT115 cell with perfect clone 
1. Add 50-200 µl of calcium competent cells to cold, sterile polypropylene tube on ice 
2. Add 2 µl of plasmid prep (1-100ng) (perfect clone) and mix gently. 
3. Incubate on ice for 30 minute 
4. Immerse tube in 37C water bath for 1 min. 
5. Incubate tube on ice/water bath for 2 min.  
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6. Add 1ml sterile SOC media. Incubate 37C with shaking for 1 hour.  
7. Plate 10uL, 100uL, 250uL, and remaining culture onto 4 LB + Kanamycin+ 
tetracycline antibiotic (plasmid resistance) plates. Incubate 37C overnight. (These cells 
grow slowly, allow 36 hours for colony formation.) 
 
 
Figure C.1  HT115 bacteria transformed with perfectly cloned targets 
Plasmids; of serotonin GPCR targets (smed.5HT-39, smed.5HT-85) in the donor vector 
pDONRdT7 were used to transform   the RNase-deficient E. coli, HT115 (with IPTG-inducible 
T7 polymerase).  Plasmid prep from the bacteria strain confirmed the presence of receptor targets 





Figure C.2  HT115 bacteria transformed with perfectly cloned Control targets 
Plasmids; of a random gene (Acon) (source, mosquito) targets in the donor vector pDONRdT7 
were used to transform   the RNase-deficient E. coli, HT115.  Plasmid prep from the bacteria 
strain confirmed the presence of gene targets in the bacteria, a confirmation necessary before the 
induction of dsRNA. 
       
   Induction of dsRNA in HT115 (DE3) cells + T7 promoter containing plasmid: 
Day 1 – Making stocks 
1. Inoculate overnight culture of HT115 (DE3) + plasmid in LB+ Kanamycin+ 
Tetracycline.  Incubate 37C with shaking overnight at 250Rev/min. (75-100ug/ml ampicillin 
for amp-resistant plasmids and 12.5 ug/ml tetracycline)  
2.  Make media (500ml final as example, scale as needed). 
 500 ml 2XYT 
 50 μg/ml KAN (2.5 ml KAN / 500 ml 2XYT for 10 mg/ml stock) 




1.  Centrifuge bacteria 10 min at 4000 RPM, 4°C. 
2. Decant supernatant, resuspend pellet in 2XYT media. 
3.  Incubate on shaker, check OD at 1 (alpha 2 may be done already), 1.5, 2 hrs, balancing 
with ~900 ul 2XYT.   
4. At an OD of 0.3 to 0.4, induce dsRNA expression by adding IPTG to a final 
concentration of 1 mM (100 mM stock = 5 ml stock / 500 ml culture). 
5.  Incubate a further 2 hr on shaker, remove, cover and put on ice to stop. 
6.  Spin cultures in 500 ml Beckman centrifuge tubes using SLA 3000 rotor (setting 30) at 
4000 RCF for 12 minutes at 4°C (NHH). 
7.  Decant supernatant and resuspend pellet in 50 ml 2XYT. 
8. Centrifuge 10 min at 4000 RPM, 4°C.   
9. With 25 ml pipette, remove 40 ml supernatant and resuspend pellet in remaining 10 ml 
(ex. for 500 ml culture and 25 ul final aliquot). 
10. Add 3 1/3 ml glycerol (250 ml glycerol: 750 ml bacteria + media). 
11. Add 665 μl of glycerol + bacteria to each microfuge tube. 
12. Get dry ice and add EtOH and freeze (keep tubes high enough so no EtOH gets in, low 









 APPENDIX D cAMP membrane preparation protocol optimized 
Motor and pestil version 
1. Wash motor and pestil several times with distilled water. 
2. Then, Wash with Sucrose buffer. 
3. Add 2ml sucrose buffer to motor and petil and place in -20 degree Celcius freezer. 
4. Fast cool centrifuge to 4 degree celcius. 
5. Fill 1 (50ml) Falcon tube with 20 ml cAMP buffer. 
6. Add 30ul (stock in minus 20 freezer) of PCK to step 5. Add also GTP (20ul (of 100 mM) 
[55mg/ml] in 20ml cAMP buffer) and ATP (20ul (of 100 mM) [55mg/ml] in 20ml cAMP 
buffer) to step 5 and mix well. 
7. Wash worms 4 times in their normal media and Transfer worms into 50ml falcon tube. 
8. Drain worm media 
9. Wash worm 1X with Sucrose buffer. 
10. Resuspend worms in 1ml Sucrose buffer 
11. Transfer worms into motor and pestil containing frozen layer of sucrose buffer. 
12. Homogenize worms with the pestil for approximately 3 min. 
13. Transfer homogenate into eppendorf tube in a final volume of 20 ml. 
14. Rinse motor to collect excess membrane on the walls of the motor and pestil 
15. Place tube on ice for 5 minutes. 
16. You may sonicate the lower portion of the sample for 5 seconds. 
17. Centrifuge at 1500 g at 1-4 degree celcius for 5 min. 
18. Transfer supernatant into fresh eppendorf tube and discard pellets. 
19. Spin the supernatant for 15 min at 15,000g. 
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20. Discard the supernatant and wash the pellets in 10 ml of sucrose buffer: resuspend 
supernatant in 10 ml of sucrose buffer and centrifuge at 15, 000g for 15min and discard 
supernatant. 
21. Resuspend the pellet in a final volume of 4ml (if worm number equals 40) of cAMP 
buffer containing Phosphofructokinase (15ul/10ml cAMP buffer), GTP (10ul (of 100 mM) 
[55mg/ml] in 10 ml cAMP buffer) and ATP (10 ul (of 100 mM) [55mg/ml] in 10 ml cAMP 
buffer) to the pellet. 
22. You may sonicate the lower portion of the sample  for 5 seconds 
23. Aliquot 400ul samples into 9 (when worm number equals 40) labeled eppendorf tubes 
for treatments. 
24. Arrange samples into consecutive groups of 3 (triplicates to receive the same treatments) 
25. Add ligands:  4ul H20 to tubes 1-3 for basal controls; 4ul of 10mM (10-2M) Forskolin to 
tubes 4-6, 4ul of 10mM (10
-2
M) 5HT to tubes 7-9, 4ul of 10mM (10
-2
M) DPAT to tubes 10-
12 and 4ul of 10mM (10
-2
M) 1, 3-CPPH to tubes 13-15, etc... 
26. Invert tube several times to mix well. 
27. Incubate for 25 min at 35 degree celcius. 
28. Centrifuge at 3000 rcf for 5 min. 
29. Transfer 350ul of the supernatant into clean tubes.  












Figure E.1  pDONRdT7 RNAi Vector 
A Double T7 Vector with a suicide gene, ccdB. The addition of PCR product of target 
receptor in the presence of BP-Clonase enzyme, results in the swaping of the region between 
attP1 and attP2 with the target gene.  This way, the transformed vector will not propagate in 
































































































APPENDIX F target sequences 
 
         S. mediterranea; Smed-ser39  
















S. mediterranea; Smed-ser85 
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